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Formation of a functional vascular system is essential for the proper development of 
Vertebrate embryos, as well for the survival of adults. In fact, blood vessels have 
various critical functions: they transport oxygenated blood to tissues throughout the 
body, and carry out catabolites and waste products. In addition, the circulatory system 
serves as a conduit for communication between distant tissues through the transport of 
hormones and allows the rapid deployment of immune responses to distal sites in the 
body (Lawson and Weinstein, 2002; Jin et al., 2005). 
The development of the vascular system in Vertebrate embryos has been extensively 
studied, due to the fact that it has a significant clinical importance. Indeed a wide range 
of congenital and acquired human diseases are associated with pathological blood 
vessels formation. Previous works uncovered many genes crucial for the development, 
growth and differentiation of vessels, including three genes we are characterizing in our 
laboratory: ve-ptp, numb and numblike. Unfortunately these genes, in addition to a lot of 
others, have not been well studied in vivo (Weinstein, 2002; Isogai et al., 2003; Jin et 
al., 2005).   
So, with the aim to improve the knowledge of the mechanisms and of the genes 
involved in vascular development we used zebrafish (Danio rerio) as model system to 
study ve-ptp, numb and numblike in an in vivo contest.  
  
FORMATION AND DEVELOPMENT OF VERTEBRATE VASCULAR 
SYSTEM 
Embryonic blood vessels formation requires several cell surface receptors and adhesion 
proteins. Several signaling molecules and transcription factor genes have been 
implicated in the development of Vertebrate vasculature: vegf, vegfr1, vegfr2, vegfr3, 
tie1, tie2, angiopoietin1, angiopoietin2, efnb2, ephB4, scl, fli1, runx, gridlock, dab2 and 
many more. A lot of them has been analyzed in zebrafish, amphibians, birds and 
mammals and displays similar temporal and spatial expression patterns (Fouquet et al., 
1997; Liao et al., 1997; Gering et al., 1998; Chin et al., 1998; Liang et al., 1998; Liao et 
al., 1998; Lyons et al., 2000; Kataoka et al., 2000; Oleinikov et al., 2000; Lawson et al., 
2001; Pham et al., 2001; Habeck et al., 2002; Torres-Vazquez et al., 2004). 
Furthermore the function of these genes appears to be conserved in all Vertebrates 
(fig.1; Carmeliet et al., 1996; Ferrara et al., 1996; Cleaver and Krieg, 1998; Lawson et 
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al., 2002; Jin et al 2005). 
 
 
Fig. 1: Differentiation scheme of zebrafish vascular/hematopoietic system. Genes involved in the 
differentiation scheme are highlighted in green. Mutant zebrafish that affect this particular stage of 
development are highlighted in red. When the gene for the mutant has been isolated, it is written in 
parentheses (adapted from Thisse and Zon, 2002).  
 
In Vertebrates there are two major morphogenetic processes that lead to a correct 
vascular development: vasculogenesis and angiogenesis (Risau, 1998). 
 
Vasculogenesis 
The cardiovascular system is the first organ system to develop in the embryo. The 
hemangioblast is the common progenitor of angioblasts and of hematopoietic stem cells 
(predecessors of endothelial and of blood cells, respectively) and differentiate in the 
lateral mesoderm where condense into aggregations called blood islands. These clusters 
show an inner layer made of hematopoietic stem cells and an external layer made of 
angioblasts (Risau, 1995; Rumpold et al., 2004; Gilbert, 2006). 
In zebrafish angioblasts arise in the posterior lateral mesoderm, close to progenitor of 
blood stem cells and between 18 somites stage and 24 Hours Post Fertilization (hpf) 
they migrate to the midline of the trunk to form the Intermediate Cell Mass (ICM; 
fig.2). The ICM is ventral to the notochord and is flanked laterally by the somites 
(Risau and Flamme, 1995; Lawson and Weinstein, 2002; Herbert et al., 2009; Swift and 
Weinstein, 2009).  
ICM angioblasts assemble into a longitudinally aligned trunk axial vessel: the Dorsal 
Aorta (DA), which lies ventral to the notochord (fig.2). Subsequently, a subpopulation 
of angioblasts sprouts ventrally from the DA and connects with adjacent cells to form 
the Posterior Cardinal Vein (PCV), founding just below and immediately juxtaposed to 
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the DA (fig.2).  
 
 
Fig. 2: Phases of vasculogenesis in the zebrafish embryo. Schematic cross sections of the trunk region 
at representative stages of development. (A) From 14 hpf onward, angioblasts (purple) that originate in 
the lateral plate mesoderm migrate over the endoderm towards the midline just below the hypochord, 
where they aggregate to form a vascular cord. (B) At around 17 hpf, angioblasts start to express arterial 
markers in arterial cells (red). These cells are located in the dorsal portion of the vascular rod and will 
give rise to the DA, whereas venous markers expressing cells are located more ventrally (blue) and will 
contribute to the PCV and CV. At 21 hpf, angioblasts located in the ventral part of the vascular cord start 
migrating ventrally and accumulate below the forming DA. (C) The DA forms and lumenizes prior to the 
PCV and CV in the absence of blood cells (brown) by cord hollowing. Venous angioblasts aggregate and 
coalesce around the blood cells to ultimately form a tube. (D) At 30 hpf, both vessels are fully formed and 
carry blood flow. Endothelial cell junctions (green); nt, neural tube; nc, notochord; h, hypochord; s, 
somites; en, endoderm (Ellertsdottir et al., 2010). 
 
In zebrafish there is only a single unpaired DA and PCV (fig.3), but in many other 
Vertebrates one or the other of these vessels are initially bilaterally paired on either side 
of the midline and fuse together to form a single tube at later stages of development (in 
mammals DA and PCV are initially both paired, whereas in Xenopus, the PCVs are 
initially paired but the DA assembles as a single tube; Zhong et al., 2001; Herbert et al., 
2009; Swift and Weinstein, 2009).  
 
 
Fig. 3: Circulation in the developing zebrafish at 24 hpf. Diagram of active vessels in the zebrafish 
embryo just before initiation of circulation, at approximately 24 hpf. This pattern is representative of 
those seen in angiograms. AA1-AA1’, mandibular arches; VA, ventral aorta; LDA-LDA’, lateral dorsal 
aortas; CCV/DC, common cardinal vein/duct of Cuvier; CA, caudal artery; CV, caudal vein (Isogai et al., 
2001). 
 
The de novo formation of main axial vessels described right now is called 
vasculogenesis.  
Successively takes place angiogenesis, the second crucial phase of vascular 
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development.  
 
Angiogenesis 
In the trunk angiogenesis leads to the establishment of a primordial network of 
Intersegmental Vessels (ISVs) subsequently modified to give rise to the definitive 
vascular tree (Risau, 1997; Roman and Weinstein, 2000). 
During a first sprouting (20-28 hpf; fig.4A) primary vessels emerge bilaterally from the 
DA, adjacent to the vertical boundaries between myotomes, and grow dorsally toward 
the nervous system. As they approach the dorsolateral roof of the neural tube, they 
divide into two major branches that turn caudally and rostrally and fuse together to form 
two bilateral Dorsal Longitudinal Anastomotic Vessels (DLAVs; fig.4B-D; Isogai et al., 
2003). Once the formation of the primary vascular network completes, a secondary set 
of sprouts begins to arise bilaterally from the PCV and grow dorsally, as did the 
primaries (1.5-2.5 Days Post Fertilization, dpf; fig.4C-E). Approximately half of the 
secondary ISVs make a connection with primaries substituting them, while the residuals 
simply regress and disappear or contribute to form other separate set of vessels (Isogai 
et al., 2003). 
 
 
Fig. 4: A model for the morphogenetic events that lead to the formation of ISV and DLAV in the 
trunk. Two neighboring sprouts are depicted as representative examples. The leading cells are indicated 
in green and purple, respectively. (A) At 22 hpf ECs of the DA form sprouts that grow along the somite 
boundaries up to the dorsal roof of the neural tube. (B, C) At the dorsal side of the embryo, the ECs cells 
send extensions toward their anterior and posterior neighbors to establish connections. (D) At around 
32 hpf, a secondary wave of angiogenic sprouts emerges from the PCV. These sprouts connect with the 
adjacent primary vessel (D, on the right), which will become a segmental vein. (E) Blood flow in ISVs 
commences after segmental arteries, segmental veins and DLAV have been established (Ellertsdottir et 
al., 2010). 
 
At 2 dpf other important vessels, the SupraIntestinal Arteries (SIAs) and the 
SubIntestinal Veins (SIVs), begin to develop near the yolk through angiogenic sprouts. 
SIAs branch out from the DA, just caudal to the pronephric glomera, while SIVs drain 
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directly into the PCV and the Common Cardinal Vein (CCV); both will provide blood 
supply to the digestive system (Isogai et al., 2001). 
Angiogenesis is not only characterized by sprouting and branching events. In the tail 
region of embryos the main axial vessels are the DA and the Caudal Vein (CV), which 
is organized in a plexus till 4.5 dpf. Starting from 2 dpf the CV plexus is drastically 
modified up to a complete re-absorption of the network of vessels. At the end of this 
angiogenic process tail will show only one venous vessel (fig.5; Isogai et al., 2001).  
 
 
Fig.5: Development of zebrafish CV plexus. (A-E’) Confocal images of CV at different developmental 
stages. (A-E) images of CV from 2 dpf to 6 dpf; (A′-E′) higher magnification images of the boxed regions 
shown in A-E. Red bars indicate the distance between the axial artery and vein (adapted from Choi et al., 
2011). 
 
 
Arterial-venous differentiation 
Early studies about Vertebrate circulatory system showed that the difference between 
arteries and veins was based on physiological factors, such as the direction and the 
pressure of blood flow (Keele, 1957). 
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Nevertheless evidence from later lineage-tracing studies indicates that some angioblasts 
might be restricted to an arterial or venous fate before the blood vessels formation or the 
onset of circulation, involving a complex interaction of several signalling pathways 
(Lawson and Weinstein, 2002).  
Some studies demonstrate that the expression of a specific arterial or venous marker, 
pertaining to the Eph-ephrin pathway, results in the acquisition of a definite endothelial 
identity. In detail ephrin-B2 (efnb2), an Eph family transmembrane ligand, marks 
arterial but not venous endothelial cells from the onset of angiogenesis. Conversely, 
Eph-B4, the receptor for ephrin-B2, marks veins but not arteries (fig.6; Wang et al., 
1998). 
 
 
Fig.6. Model of ephrinB2-EphB4 expression in arterial and venous endothelium. ephrinB2 is 
exclusively expressed in arterial endothelial cells, whereas EphB4 in venous endothelial cells. Both are 
under control of the same pathways (Shh and Notch; adapted from Lin et al., 2007).  
 
The expression of these markers is predominantly under control of two factors working 
upstream (fig.6, fig.7): Notch and Sonic Hedgehog Homolog (SHH; Smithers et al., 
2000; Lawson et al., 2001; Villa et al., 2001).  
SHH induces somitic tissue to express vegf playing an important role for determination 
of cell types that lie adjacent to the notochord (fig.7; Odenthal et al., 1996; Lawson et 
al., 2002). The exposure of angioblasts to Vegf induces the Notch signaling which 
results in the expression of arterial-specific genes in the presumptive arterial cells, while 
in venous territory leads to the repression of arterial cell fate (fig.7; Odenthal et al., 
1996; Lawson et al., 2002; Lawson and Weinstein, 2002). 
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Fig.7. Model of signalling pathways responsible for arterial-
venous differentiation. Diagram of a cross-section through a 
zebrafish trunk at approximately 24 hpf. NT, neural tube; NC, 
notochord (adapted from Lawson et al., 2002). 
 
 
 
ZEBRAFISH AS A DEVELOPMENTAL MODEL SYSTEM  
Zebrafish (Danio rerio) is a tropical fish native to Southeast Asia. It possesses a unique 
combination of features that makes it particularly well suited for experimental and 
genetic analysis of early vertebrate development.  
Zebrafish adults are small, so many fishes can be housed in a small space. They have a 
relatively short generation time, an adult female reaches the sexual maturity in about 
three months and it lays hundreds of eggs per mating every few weeks, generating many 
progeny for genetic or experimental analysis. The zebrafish eggs are fertilized and 
develop externally to the mother, providing ready access to the developing animal at all 
stages of its development. The fertilized embryos develop rapidly, making it possible to 
observe the entire course of early development in a short time. Somitogenesis begins at 
about 9 hpf and at 24 hpf the zebrafish embryo has already formed all the major tissues 
and many organ precursors, such as a beating heart, circulating blood, nervous system, 
eyes and ears, all of which can be readily observed under a simple dissecting 
microscope. Larvae hatch by about 2.5 dpf and they are swimming and feeding by 5–6 
dpf (Sumanas and Lin, 2004; Weinstein, 2002).  
A variety of tools and methodologies have been developed to exploit the advantages of 
the zebrafish system. Zebrafish embryos and early larvae are optically clear, allowing 
for direct, non-invasive observation or experimental manipulation at all stages of their 
development such as Whole-mount In Situ Hybridisation (WISH) analysis of gene 
expression patterns with extraordinarily high resolution (Vogel and Weinstein, 2000). 
The externally developing embryos are readily accessible to experimental manipulation 
by techniques such as microinjection of biologically active molecules (RNA, DNA or 
antisense oligonucleotides), cell transplantation, fate mapping and cell lineage tracing 
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(Holder and Xu, 1999; Kozlowski and Weinberg, 2000; Mizuno et al., 1999; Reifers et 
al., 2000; Stainier et al., 1993). 
The genetic methods available in the fish have been complemented in the last few years 
by a full array of genomic and molecular genetic tools. Relatively dense meiotic and 
radiation hybrid maps now allow for the rapid genetic and physical localization of 
mutations and genes (http://zfish.uoregon.edu). Large-insert clones of genomic DNA 
are available from Yeast Artificial Chromosome (YAC), Bacterial Artificial 
Chromosome (BAC) and P1 Artificial Chromosome (PAC) libraries. Extensive 
Expressed Sequence Tag (EST) sequencing and mapping projects are underway 
(http://zfish.wustl.edu). Efforts have also been initiated to obtain the complete sequence 
of the zebrafish genome, a feat that will undoubtedly dramatically increase the 
usefulness of the mutants and genetic tools available in the fish (Vogel and Weinstein, 
2000). 
 
ZEBRAFISH AS A MODEL SYSTEM TO STUDY VASCULOGENESIS AND 
ANGIOGENESIS IN VIVO 
The development of the vasculature has been extensively examined in a variety of 
Vertebrates, but in vivo studies of vasculogenesis/angiogenesis have been traditionally 
difficult. 
In Vertebrates to observe blood vessels directly in living embryos is often difficult, it 
dues to their opacity or development internal to the mother. Shortly after 24 hpf 
zebrafish embryos present blood circulation and most adult organs are forming; 
moreover zebrafish embryos are readily observable under a simple dissecting 
microscope (Vogel and Weinstein, 2000; Amatruda and Zon, 1999). The optical clarity 
and accessibility of the zebrafish embryo also permit efficient application of 
experimental embryologic methods for in vivo analysis of vascular development, 
notably confocal microangiography. In fact it’s possible to inject fluorescent beads into 
the blood flow in order to visualise the entire vascular tree in vivo (Weinstein et al., 
1995).  
Because of their small size, zebrafish embryos also receive enough oxygen by passive 
diffusion from external medium to survive and continue to develop in reasonably 
normal fashion for several days even in the complete absence of blood circulation, 
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facilitating phenotypic analysis of animals with circulatory defects (Stainier, 2001). 
This combination of features has made it possible to perform large-scale forward-
genetic mutant screens to isolate embryonic and early larval lethal mutations in the 
zebrafish (Driever et al., 1996; Haffter et al., 1996), including many that specifically 
affect the cardiovascular system (Chen et al., 1996; Stainier et al., 1996; Weinstein et 
al., 1995). Zebrafish embryos and larvae are raised in an aqueous environment and are 
readily permeable to many different compounds in their culture media. By simply 
adding the chemicals or drugs to the zebrafish embryo culture water, potential pro or 
antiangiogenic activities of these substances can be rapidly and easily evaluated along 
with the assessment of additional unwanted teratogenic or toxic side effects on other 
developing organs. This method has already been successfully used to treat zebrafish 
with known inhibitors of specific growth factors like Vegf to study angiogenic 
signalling (Chan et al., 2002), or to study the effects of toxins on vascular development 
(Cheng et al., 2001). 
In addition transgenic zebrafish, with green fluorescent vessels, have been generated. 
The application of transgenic technology to the zebrafish (Jowett, 1999) has resulted in 
the ability to create or enhance in vivo imaging capabilities and spatially and temporally 
control gene expression. Transgenic zebrafish lines expressing Green Fluorescent 
Protein (GFP) within vascular endothelial cells have been particularly useful for 
studying the formation of the vasculature in vivo (Lawson and Weinstein, 2002a; Kidd 
and Weinstein, 2003). 
Zebrafish is a good model for comparative studies of vascular development. 
Comparison between the blood vessels of zebrafish and other vertebrates also reveals a 
striking degree of anatomical and functional conservation of vascular pattern. For 
example, most of the cranial vessels in 2.5–3.5 dpf zebrafish are also found in other 
developing Vertebrates. These vessels include the aortic arches, lateral dorsal aorta, 
internal carotid arteries, primordial hindbrain channel, anterior cardinal vein and basilar 
artery. This conservation of vascular anatomy suggests that vascular development is 
directed by genetically programmed and evolutionarily conserved control mechanisms 
and that the information obtained from zebrafish should be readily transferable to other 
Vertebrates. Indeed, the analysis of various vascular-specific genes first identified and 
described in other species confirms a high degree of evolutionary conservation between 
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orthologous (Roman and Weinstein, 2000; Weinstein, 2002; Kidd and Weinstein, 
2003).  
 
VE-PTP 
The regulation of endothelial cell contacts is of central importance for the physiological 
role of the endothelium as a barrier between blood and tissue and for the formation and 
maintenance of blood vessels; in fact the formation and outgrowth of blood vessels, as 
well as the control of vascular permeability, are dependent on dissociation, 
rearrangement and re-closure of inter-endothelial cell junctions (Schnittler, 1998; 
Dejana et al., 2000; Vestweber, 2000).  
Ve-ptp is a trans-membrane protein that constitutes endothelial junctions and, 
interacting with VE-cadherin (Vascular Endothelial cadherin), may play parts in the 
regulation of molecular interactions between proteins of cell-to-cell junctions. 
Consequently Ve-ptp may result crucial for cell migration and proliferation, cellular 
signalling and changes in para-endothelial permeability (Fachinger et al., 1999). 
 
Molecular organisation of endothelial junctions  
Endothelial cells have specialized junctional regions, which are comparable to TJs 
(Tight Junctions) and AJs (Adherens Junctions) that characterize epithelial tissues. The 
distribution and the organisation of these junctions change along the vascular tree in 
regard to different requirement of permeability. The several molecules forming AJs and 
TJs share common features despite they differ in structure; for instance in both junction 
types the adhesion is mediated by trans-membrane proteins: VE-cadherin in AJs and the 
members of the Claudin family, Occludin, JAMs (Junctional Adhesion Molecules) and 
ESAM (Endothelial cell Selective Adhesion Molecule) in TJs (fig.8). All these 
junctional adhesion proteins bind intracellular proteins with their cytoplasmic domain, 
such as Catenins, a-actinin, ZO-1, ZO-2 and Plakoglobin, that anchor them to 
cytoskeletal filaments, important for the junction stability and for the dynamic 
regulation of junction opening and closure (fig.8; Schnittler, 1998; Dejana, 2004).  
Some intracellular and transmembrane proteins at AJs are kinases and phosphatases, 
such as SHP2 (Src-homology-2 (SH2)-domain-containing protein tyrosine phosphatase-
2) and DEP1 (Density Enhanced Protein-1), also known as CD148. The only known 
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phosphatase whose expression appears to be restricted to vascular endothelial cells is 
Ve-ptp, a specific Vascular Endothelial-Protein Tyrosine Phosphatase (Fachinger et al., 
1999).  
 
           
Fig. 8: A schematic representation of the molecular organisation of endothelial junctions (Dejana, 
2004). 
 
Protein tyrosine phosphatase super-family 
Protein tyrosine phosphorylation is an critical role in a lot of events during cell growth 
and differentiation (Ullrich and Schlessinger, 1990). The level of tyrosine 
phosphorylation is determined by the opposing actions of PTKs (Protein Tyrosine 
Kinases) and PTPs (Protein Tyrosine Phosphatases). In contrast with the extensive 
analysis and information on the role of PTKs, studies on the physiological importance 
of PTPs are limited (Tonks et al., 1988; Kuramochi et al., 1996). All PTPs have an 11 
amino acids conserved consensus motif (I/V)HCXAGXGR(S/T)G (X can be any amino 
acid); the cysteine and arginine residues within the consensus motif are essential for the 
PTP activity (Kuramochi et al., 1996; Guan and Dixon, 1991).  
Members of the PTP super-family can be divided in classical PTPs or Dual-Specificity 
Phosphatases (DSPs, fig.9). Classical PTPs contain one or two catalytic domains that 
surround the signature motif, called PTP domain, and their catalytic action is principally 
direct to pTyr residues. Classical enzymes are further subdivided into transmembrane 
receptor-like (RPTPs) and non-transmembrane (non-TM) forms, on the basis of the 
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sequences that flank their PTP domains. Flanking domains offers a potential binding 
site for regulatory ligands, thus permitting regulation of RPTP activity, either directly or 
indirectly, in response to specific stimuli. Most RPTPs have two intracellular PTP 
domains but the reason for this remains unclear. In almost all cases, the more carboxy-
terminal PTP domain has little or no catalytic activity but may function as a site of 
interaction with regulatory/targeting proteins (Tonks et al., 1988; Kuramochi et al., 
1996; Guan and Dixon, 1991). Similarity between classical PTPs and DSPs is restricted 
to the signature motif, although there is conservation in the fold of the catalytic domain 
(Yuvaniyama et al., 1996; Fauman et al., 1998). As their name implies, DSPs typically 
dephosphorylate both pTyr and pSer/pThr residues (Tonks and Neel, 2001). 
Ve-ptp belongs to the unique subclass of receptor-type PTPs bearing exclusively 
fibronectin type III-like repeats in the extracellular domain and a single catalytic 
domain in the cytoplasmic tail (Brady-Kalnay and Tonks, 1995; Nawroth et al., 2002). 
 
 
Fig. 9: A schematic representation of different types of the tyrosine phosphatase super-family 
members. The classical (phosphotyrosine-specific) PTPs are shown on the left hand side. These can be 
subdivided further into non-transmembrane and receptor-like PTPs. On the right are the dual-specificity 
phosphatases (DSPs). PTP (catalytic) domains are shown as large or small ovals for classical PTPs and 
DSPs respectively. Structural features of PTP regulatory (i.e. non-catalytic) domains are shown in the 
boxed inset (Tonks and Neel, 2001). 
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Identification and expression pattern analysis of mouse Ve-ptp  
The RTK (Receptor Tyrosine Kinase) activity in endothelial cells is essential for 
vasculogenesis and angiogenesis, so reasonably endothelial cells-specific PTPs play an 
important role in the balancing signals with RTKs (Hanahan, 1997; Risau, 1997).  
In order to detect endothelial specific members of the protein-tyrosine phosphatase 
family a murine brain capillary cDNA library has been screened identifying a PTP 
specifically expressed in vascular endothelial cells called Ve-ptp (Krueger et al., 1990; 
Fachinger et al., 1999). 
The Ve-ptp cDNA contained a 5’ UTR (UnTranslated Region) of 130 bp, a 3’ UTR of 
32 bp and an open reading frame of 5994 bp encoding a polypeptide of 1998 
aminoacids. Structural prediction programs identified 17 extracellular fibronectin type 
III-like repeats (FNIII repeats), one putative transmembrane domain and one 
intracellular phosphatase domain (PTP domain). Sequence comparison revealed 83% 
identity of the full-length amino acids sequence with the human homologue HPTPβ, 
while the intracellular part of the protein sequence was 94% identical to the 
corresponding part of HPTPβ (Nawroth et al., 2002). 
The structure of the Ve-ptp extracellular domain suggests a role of this protein as an 
adhesion receptor. VE-cadherin is the essential adhesion molecule in endothelial 
adherens junctions and is directly involved in the maintenance of endothelial cell 
contacts in vitro and in vivo (Lampugnani et al., 1992; Gotsch et al., 1997; Corada et 
al., 1999). Surprisingly, VE-cadherin is dispensable for initial vessel formation, but it is 
required for their maintenance (Crosby et al., 2005). The interaction between VE-
cadherin and Ve-ptp is the first demonstrated interaction that involves exclusively the 
membrane-proximal extracellular domains of these junctional proteins. It is possible 
that the direct binding between these domains affects the conformation or the clustering 
of VE-cadherin, thus influencing its adhesive activity. Moreover, it is supposed that Ve-
ptp recruits and/or activates an unidentified phosphatase that directly dephosphorylates 
VE-cadherin so affecting cell layer permeability. As both the enzymatically inactive and 
enzymatically active form of Ve-ptp inhibits VE-cadherin phosphorylation, it also 
suggests that phosphatase activity of Ve-ptp is not required for cadherin 
phopsphorylation (Nawroth et al., 2002). 
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Northern blot, RT-PCR analysis and in situ hybridisation have been later performed to 
analyse the expression pattern during the embryonic development and in the adult 
tissues.  
Northern blot assays revealed a strong expression of Ve-ptp mRNA in lung, heart and 
brain and a weaker expression in kidney and liver of adult mice. Semi-quantitative RT-
PCR performed with RNA obtained from mouse organs confirmed these data while RT-
PCR analysis on RNA extracted at different developmental stages showed that during 
embryonic development Ve-ptp expression was weak at E11 (Embryonic day 11), 
increased at E15 and reached the maximum at E17 (Fachinger at al., 1999). 
The expression pattern analysis of Ve-ptp mRNA was also performed by in situ 
hybridisations on frozen sections of mouse embryonic tissues. At the earliest stage 
analysed (E9.5), expression was detectable in the endothelial cell layer lining the dorsal 
aorta and during the subsequent developmental stages it was increased throughout the 
developing vascular system (fig.10a-d). Moreover, strong hybridisation signals were 
visible in endothelial cells forming blood vessels, whereas no specific signals were 
detected in blood cells or smooth muscle cells surrounding the vessels (fig.10b-c). At 
E15.5 specific signals were detectable in all organs with highest expression in the lung. 
Comparison to serial sections hybridised with an antisense probe of Vegfr-2 (Vascular 
Endothelial Growth Factor Receptor 2, Flk-1), an endothelial cell marker (Millauer et 
al., 1993), confirmed the vascular endothelial specific expression pattern of Ve-ptp. In 
contrast to the uniform expression levels of Vegfr-2 in different types of embryonic 
endothelial cells, Ve-ptp is more strongly expressed in endothelial cells lining larger 
vessels than those of small capillaries and veins. On brain sections of newborn mice, 
specific expression of Ve-ptp was detectable in brain capillaries as well as in larger 
vessels, and no specific signals were visible in neuronal or glial cells (Fachinger at al., 
1999). 
Fig.10: Expression analysis of Ve-ptp by 
in situ hybridisation on embryonic 
tissues sections. (a) Dark field image of 
an E12.5 embryo section hybridised with a 
Ve-ptp antisense probe. NC: neural crest, 
DA: dorsal aorta, (b) dark field and (c) 
bright field image of a higher 
magnification of the vessel indicated in a 
(asterisk), (d) sagittal sections of E15.5 
embryos head region (Fachinger at al., 
1999). 
 
* 
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Ve-ptp mutants and null-mice 
In order to analyse Ve-ptp function in the vascular system development have been 
generated mice carrying a gene disruption leading to the expression of a truncated, 
secreted form of Ve-ptp lacking the complete intracellular and transmembrane domains 
and the most membrane proximal extracellular fibronectin type III-like repeat. This 
strategy led to the expression of nuclear β-galactosidase under the control of the 
endogenous Ve-ptp promoter (Bäumer et al., 2006). 
Homozygous mutant embryos (mt/mt) died at E10 and before E8.5 no phenotypic 
alterations are visible. Between E8.5 and E9.5 homozygous mutant embryos show 
growth retarded, displayed an enlarged pericardial cavity and an incomplete heart 
turning (fig.11C-D). At this developmental stage, embryos showed vascular pattern 
disorganization, in particular in cerebral and intersomitic vessels (fig.11E-H). In fact de 
novo blood vessels formed normally in mutant mice, whereas intraembryonic and 
extraembryonic vasculature showed dramatic defects in remodelling (fig.11A-B), 
suggesting an important role of Ve-ptp in blood vessel remodelling and angiogenesis. 
On the other hand heterozygous mutants mice (+/mt) were phenotypically 
indistinguishable from the wild-type (wt; fig.12A-B), and presented comparable rates of 
viability and fertility.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Developmental and vascular defects in Ve-ptp-lacZ mutant embryos. (A) Normal 
vascularisation in an E9.5 wt yolk sac, (B) pale yolk sac of a Ve-ptpmt/mt embryo with blood islands (white 
arrows), (C) growth retardation in a rare E10.0 homozygous Ve-ptp mutant, stained for β-galactosidase. 
The Ve-ptp+/mt embryo on the left had 25 somite pairs, whereas its Ve-ptpmt/mt littermate on the right was 
less than half the size and had only 10 somite pairs. (D) Pale-looking E9.5 Ve-ptp homozygous mutant 
embryo with severely enlarged pericardium (asterisk). d: dorsal; v, ventral. (E-H) E9.0 embryos 
immunostained for PECAM-1. (E) Well-organized cerebral vascular network (arrows) in an E9.0 wild-
 
 18 	  
type embryo brain, (F) disconnected clusters of endothelial cells (arrows) in a Ve-ptpmt/mt littermate, (G) 
well-defined intersomitic sprouts (asterisks) in an E9.0 wild-type embryo, whereas intersomitic vessels 
(black arrows) failed to develop in a homozygous mutant embryo (H) (Baumer et al., 2006). 
 
Ve-ptp expression pattern was analysed both during embryonic development and in 
different tissues from adult heterozygous mice by β-galactosidase staining and by 
immunohistochemistry. It revealed a distinct vascular pattern of Ve-ptp expression with 
a remarkable preference for arterial endhotelium (fig.12C-D). Furthermore 
immunohistochemistry analysis of (+/mt) adult organs cryosections with an antiboby 
against Ve-ptp and PECAM-1 (Platelet/Endothelial Cell Adhesion Molecule-1) showed 
that arterial endothelium was stained much more strongly than the venous (fig.12C, D). 
All these data revealed that Ve-ptp protein and transcriptional expression were more 
prominent in arterial than in venous endothelium (Bäumer et al., 2006). 
 
Fig.12: Ve-ptp is predominantly 
expressed in arterial endothelium. 
(A) Whole mount β-galactosidase 
staining of an E12.5 Ve-ptp+/mt embryo 
showing a distinct vascular pattern of 
Ve-ptp transcriptional activity 
(represented by the lacZ expression 
pattern), whereas the same staining of 
a wild type littermate (B) was 
negative. C-D Cryosections of an adult 
Ve-ptp+/mt heterozygous kidney. (C) An 
arterial vessel (ar) is immunolabeled 
for PECAM-1 (red) and endothelial 
nuclei are β-galactosidase stained 
(blue), recording Ve-ptp transcriptional 
activity, (D) immunolabeling for Ve-
ptp with mAb 109.3 (red) and β-
galactosidase staining (arrow depicts endothelial nuclei). Ar: arterial endothelium; ve: venous 
endothelium (Bäumer et al., 2006). 
 
Afterwards have been generated Ve-ptp null mice in which Ve-ptp was replaced by lacZ 
to elucidate the functional role of Ve-ptp in vascular development (Dominguez et al., 
2007). By this way it has been confirmed the Ve-ptp expression in both arterial and 
venous endothelial cells, with a preferential expression in arterial vessels and it has been 
demonstrated that Ve-ptp is essential for a correct cardiovascular development. In fact, 
Ve-ptp KO (Knock-Out) embryos appeared developmentally delayed starting at E9.0 
and smaller than the controls (fig.13A-B), also showing vascular defects in areas where 
the remodelling should take place (fig.13C-F). In these embryos, the cephalic plexus 
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failed to remodel into a hierarchical branched vascular network and it remained as a 
plexus with only minor pruning (fig.13C-D). Moreover cross sections of PECAM-1 
immunostained E9.0 embryos revealed abnormalities also in the main vessels; dorsal 
aortas were smaller and had a narrowed lumen than in control embryos, while cardinal 
veins appeared poorly defined and incompletely reshaped (fig.13G-H). 
 
 
Fig.13: Defects in vascular remodelling in Ve-ptpLz/Lz null-mice embryos. (A–F) Whole mount 
PECAM-1-stained E9.5 embryos. Ve-ptpLz/+(A, C, and E) compared with a Ve-ptpLz/Lz littermate (B, D, 
and F). (C and D) A close up of the head vasculature shows the normal remodelling pattern of veins (blue 
arrows) and arteries (red arrows) in Ve-ptpLz/+ embryos (C). In Ve-ptpLz/Lz embryos, the venous plexus 
(blue arrows) undergoes only minor remodelling (D). (E and F) Close up of the cardinal vein (blue 
arrows), which does not form correctly in Ve-ptpLz/Lz embryos (F). (G and H) PECAM-1 immunostaining 
of E9.0 embryo cross sections at heart level. The dorsal aortas (red arrows) are small and collapsed in Ve-
ptpLz/Lz embryos (H) compared with wt (G), and the cardinal veins (blue arrows) are diffuse and not 
clearly delineated (blue arrow) (Dominguez et al., 2007). 
 
Identification and expression pattern of ve-ptp in zebrafish. 
 ve-ptp in zebrafish has been identified in our lab and encode for a 1892 aa polypeptide, 
showing the same domains previously described in mouse: a cytoplasmic catalytic 
domain, called PTP domain, a trans-membrane region and an extracellular domain 
organized in 15 Fibronectin type III (FNIII) like repeats (fig.14). 
 
 
Fig.14: Homolog of Ve-ptp in zebrafish. zVe-ptp exhibit three characteristic regions: an extracellular 
domain (blue), a catalytic domain (red) and a transmembrane region (green). 
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In order to evaluate the spatial expression pattern, WISH has been conducted on 
embryos fixed at different developmental and larval stages (26 hpf, 40 hpf, 2 dpf and 3 
dpf; fig.15A-D). This analysis revealed that ve-ptp in zebrafish is expressed in 
developing vascular system, highlighting a strong similarity with murine expression 
pattern. At 26 hpf the mRNA was detectable in the DA and in CV plexus (fig.15A-B) 
and later in the cephalic vessels, in the aortic arches, in the CCV, in the ISVs, in the 
DLAVs, in the bulbus arteriosus and in the atrium of the heart (fig.15C-D). Afterwards 
RT-PCR analysis has been conducted on total RNAs extracted from different 
embryonic and larval stages and from various adult organs to determine temporal and 
spatial expression of zve-ptp. In embryos the transcript was observed since the first 
developmental stages, while in adult was detected in each organ analysed (fig.15E-F; 
Carra et al., manuscript under revision). 
 
 
 
Fig.15: Expression pattern of zve-ptp. On the left: WISH analysis. (A) Lateral and (B) dorsal picture of 
a 26 hpf embryo; the transcript is expressed in DA (black and white arrows) and in CV plexus (white 
arrowhead). Lateral vision of (C) cephalic and (D) tail region of a 3 dpf embryo. Hybridization signal is 
detectable in cranial vessels (blue arrow), aortic arches (white asterisk), ISVs (yellow arrow) and DLAVs 
(red arrow). All the embryos are shown with head on the left. On the right: RT-PCR assays. Temporal 
expression analysis on total RNAs extracted from (E) different embryonic and larval stages and from (F) 
adult organs. β-actin serves as internal control (Carra et al., manuscript under revision). 
 
 
Loss of function analysis of zVe-ptp. 
To clarify the role of Ve-ptp during vascular development, knockdown assays have 
been conducted microinjecting in vivo a specific morpholino (ve-ptpMO).  
A morpholino (MO) is a synthetic antisense oligonucleotide 25 bp long, which is 
complementary to a specific sequence of the mRNA target (Nasevicius and Ekker, 
2000). Morpholinos have been successfully used in Xenopus laevis and zebrafish to 
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knockdown gene function by preventing the translation (fig.16; Ekker, 2000) or by 
modifying the splicing of pre-mRNA of the target gene. Alteration of the splicing 
events may cause a specific exon skipping or the retention of an intron and its insertion 
in the mature mRNA (fig.16; Kole and Sazani, 2001). 
   
Fig.16. Mechanisms of function of morpholinos. Created by Jon D. Moulton of Gene Tools, LLC, 
made available under the GNU Free Documentation License {{GFDL-self}}. 
 
Embryos may be injected since 1 cell stage to 4 cells stage; so microtubule-mediated 
movement spreads MO in all the blastomeres (Nasevicius and Ekker, 2000).  
During loss of function experiments it is crucial to identify the working dose of MO to 
inject, testing precautionarily different dosages of MO. Indeed the seriousness of the 
defects/phenotypes obtained is dose-dependent: higher doses correspond to severe 
defects and high mortality and vice versa. Therefore working dose must keep down 
mortality and maintain the body plan, producing detectable defects (Nasevicius and 
Ekker, 2000). In order to exclude that the obtained phenotypes are unspecific 
consequences of a microinjection and to validate their specificity, parallel experiments 
have been conducted, injecting a std-ctrlMO that hasn’t got any target in zebrafish. 
Embryos, microinjected with 0.5 pmol/embryo of ve-ptpMO (called morphants), have 
been first observed in vivo evaluating vascular defects and then subdivided into four 
phenotypic classes. Subsequently, plastic sections of the members of these classes have 
been made, to characterize in detail the observed alteration (fig.17; Carra et al., 
manuscript under revision).  
• CL.I, 19%; the embryos belonging to this class were totally comparable with 
controls. 
• CL.II, 62%; these morphants showed cephalic micro-haemorrhage and clots of 
blood cells in the tail, especially in the CV plexus, which anyway don’t obstruct 
the blood circulation (fig.17C-D). Analysis of sections revealed that all the 
blood cells making the clots were crammed inside the vessels (fig.17E). 
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• CL.III, 11%; the embryos making up this phenotypic class displayed pericardial 
oedema, an accumulation of blood cells in the sinus venosus and a complete 
absence of blood circulation, despite the heart beat was unaltered (fig.17F). 
Transverse sections showed an increased calibre of CV (fig.17G).  
• Cl.IV, 8%; these morphants had a damaged body plan and didn’t display blood 
circulation. Moreover these embryos exhibited a considerable accumulation of 
blood cells in CV plexus and, analysing plastic sections, extravasation of cells 
was detectable in the tail region (fig.17H-L). Additionally this region showed a 
severe enlargement of the CV (fig.17L). 
 
Fig. 17: Loss of function analysis. (A, B) std-
ctrl MO injected embryo, (C-L) ve-ptpMO 
injected embryos belonging to CL.II, CL.III 
and CL.IV. (A, C, D, F, H, I) in vivo images of 
(A, F, H) whole mount embryos and of close 
up of (C) head and of (D, I) tail. (B, E, G, L) 
transverse sections of the embryos previously 
analysed in whole mount. Micro-haemorrhage 
(black arrow), clots in the CV plexus (white 
arrowhead), blood cells accumulation in 
pericardial region (white arrow), pericardial 
oedema (red arrow), blood cells accumulation 
in the CV region (black arrowheads). Sections 
are collected at the levels showed from the red 
line. All the embryos are shown with head on 
the left (adapted from Carra et al., manuscript 
under revision). 
 
 
 
 
NUMB AND NUMBLIKE 
Cell fate decisions are crucial events during embryonic development and take place by 
complex mechanisms of asymmetric segregation of several mRNA and proteins during 
cell division (fig.18; Cayouette and Raff, 2002). 
 
 23 	  
 
Fig.18: Symmetric and asymmetric segregation of a cell-fate determining protein that is localized to 
the apical cortex in vertebrate neuroepithelial cells. (a) In a cell division with a horizontal mitotic 
spindle (oriented parallel to the plane of the neuroepithelium), the cell fate protein (blue) is inherited by 
both daughter cells. (b) In a cell division with a vertical mitotic spindle, it is inherited by only one 
daughter cell (Cayouette and Raff, 2002). 
 
Numb is a membrane-associated protein first identified in Drosophila melanogaster 
where may be asymmetrically located at one pole of the cell. Hence during mitosis this 
protein can be inherited unequally by the two daughter cells, directing them to different 
fates (Rhyu et al., 1994; Spana et al., 1995; Zhong et al., 2000). Therefore it is plain 
that the correct distribution of this protein is essential to promote differentiation toward 
a specific cell fate (Guo et al., 1996; Verdi et al., 1996; Zhong et al., 1996; Zhong et al., 
2000). 
 
Functions of Numb and Numblike 
Genes homologous to dnumb have been identified in different Vertebrates (mouse, rat, 
chicken and human) showing that similar structure is conserved through evolution. A 
homolog of Numb, called Numblike, has also been characterized in mouse (Verdi et al., 
1996; Zhong et al., 1996; Zhong et al., 1997; Wakamtsu et al., 1999).  
Mammalian Numb and Numblike act as adaptor protein interacting with several 
molecules and regulating multiple cell functions (fig.19). A number of pathways, which 
control cell development, have been described to interact with Numb and/or Numblike 
(Androutsellis-Theotokis et al., 2006; Jiang and Hui, 2008). Furthermore in mammals 
their roles seem to be overlapped, although recent studies suggest they may maintain 
some distinct functions (Gulino et al., 2010).  
A critical region for determining Numb and Numblike functions is the amino terminal 
PhosphoTyrosine-Binding domain (PTB), characteristic region of these proteins in all 
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Vertebrates. PTB domain binds diverse proteins, as the ubiquitin ligase Itch (fig.19), 
which causes degradation and function inhibition of Notch and Gli1 (a SHH pathway 
transducer; McGill and McGlade, 2003; Di Marcotullio et al., 2006). 
PTB domain is also partially involved in cell membrane localization (fig.19), 
contributing to the role of Numb and Numblike in the regulation of Notch receptor 
pathway (Santolini et al., 2000). 
 
 
Fig.19: Structure–activity relationships of Numb. Numb levels are regulated by Musashi and 
miR146a, ubiquitination by LNX, Siah-1 and Mdm2 and phosphorylation by aPKC and calcium-
calmodulin. Numb interacts with Itch to ubiquitinate Notch and Gli1, with Mdm2 to hamper 
ubiquitination of p53, with endocytic machinery to control Notch trafficking and with cadherin and 
integrins to control cell adhesion and migration. APP: amyloid precursor protein (Gulino et al., 2010).  
 
Numb was originally identified as an inhibitor of Notch signaling in D. melanogaster; 
in fact, recruiting Itch, an E3-ubiquitin ligase belonging to Nedd4 family, leads to 
polyubiquitination and degradation of Notch Inter Cellular Domain (ICD; McGill and 
McGlade, 2003; McGill et al., 2009). 
Furthermore Numb may also control the intracellular trafficking of Notch, causing 
endocytosis and sequestration of full-length Notch or Notch ICD, thereby suppressing 
their function (Knoblich, 2008; Gulino et al., 2010).  
 
Role of Notch during vascular development 
Notch has been first characterized in D. melanogaster and encodes for a trans-
membrane receptor, which plays a critical role in cell fate determination (Kidd et al., 
1986; Weinmaster, 1997; Artavanis-Tsakonas et al., 1999). 
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Successive studies in mammals revealed the presence of four different Nocht receptors 
and six ligands: Jagged (1 and 2) and Delta (1, 2, 3 and 4; Weinmaster et al., 1991; 
Weinmaster et al., 1992; Lardelli et al., 1994; Lindsell et al., 1995; Uyttendaele et al., 
1996; Dunwoodie et al., 1997; Jen et al., 1997; Luo et al., 1997; Shutter et al., 2000). 
The bond between Notch and its ligand produce two proteolytic cuts of the receptor 
activating the ICD (fig.20; Mumm and Kopan, 2000). Then this dominium translocate 
in the nucleus where bind a C promoter binding factor 1, Suppressor of hairless, Lag1 
(CSL) thus interact with DNA (fig.20). This interaction switches CSL from suppressor 
to transcriptional factor (Ong et al., 2006). 
 
 
Fig.20. The core pathway of Notch signaling. Proneural genes such as Mash1 and Ngn2 promote 
neuronal differentiation and induce the expression of Dll1, which in turn activates Notch in neighboring 
cells. Upon activation of Notch, the Notch intracellular domain (NICD) is released from the 
transmembrane portion and transferred to the nucleus, where it forms a complex with the DNA-binding 
protein Rbpj and the transcriptional co-activator Maml. The NICD–Rbpj–Maml complex induces the 
expression of transcriptional repressor genes such as Hes1 and Hes5. Hes1 and Hes5 then repress the 
expression of proneural genes and Dll1, thereby leading to the maintenance of neural stem/progenitor 
cells. Numb inhibits Notch signaling and induces neuronal differentiation (Shimojo et al., 2011). 
 
Notch signaling is an evolutionarily conserved regulatory circuitry implicated in cell 
fate determination in various developmental processes including neurogenesis, 
myogenesis, oogenesis, development of the eye, hematopoietic stem cell self-renewal 
and differentiation of blood lineages (Greenwald, 1998; Bray, 1998; Bresciani et al., 
2010). 
Moreover it has been shown that Notch pathway plays a key role during vasculogenesis 
and angiogenesis and that it is required for arterial-venous differentiation of endothelial 
cells during embryonic development (Xue et al., 1999; Krebs et al., 2000; Thirston and 
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Yancopoulos, 2001; Raya et al., 2003; Krebs et al., 2004). 
As a rule Notch pathway acts by a mechanisms called lateral inhibition. Two cells 
exhibiting receptors and ligands transmit and receive signals; a modification in this 
exchange of information cause a transcriptional feedback response that produce an 
amplification of the alteration. So one cell will express predominantly Notch and 
otherwise the adjacent cell express the ligands (Artavanis-Tsakonas et al., 1999). 
Several studies demonstrated that Notch is implicated in vascular development of 
Vertebrates. In zebrafish, chicken and mice angioblasts and differentiated endothelial 
cells express Notch (1-4) and a number of its ligands, as Dll4, Jag1 and Jag2 
(Shirayoshi et al., 1997; Vargesson et al., 1998; Krebs et al., 2000; Lawson et al., 2001; 
Villa et al., 2001). However Notch signaling member’s expression is restricted to 
arterial endothelium and it is completely absent in veins, suggesting a role of Notch in 
acquisition of arterial identity of the vessels. To verify this hypothesis in zebrafish it has 
been generated mindbomb dll4-/- mutants (mib) who failed to activate Notch receptors 
causing a complete lost of functionality of its pathway (fig. 21 A-F; Jiang et al., 1996). 
mib mutants didn’t express notch3 and the arterial markers efnb2 and showed an ectopic 
expression of venous markers in arterial territory (fig. 21 A-F; Lawson et al., 2001).  
 
Fig. 21: Expression of arterial and venous markers in mib mutants. WISH of arterial (ephrinb2, 
notch3) and venous (flt4) markers. A, C, E control embryos; B, D, F mutants. In mutants arterial markers 
are down regulated and inversely venous are up regulated. Arrows and arrowheads highlight the 
hybridization signals. All the embryos are shown with head on the left. (adapted from Lawson et al., 
2001). 
 
Contrariwise ubiquitary expression of Notch ICD caused ectopic expression of arterial 
markers to the detriment of venous (fig. 22 A-F; Lawson et al., 2001). 
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Fig. 22: Expression of arterial and venous markers in embryos in which Notch ICD expression is 
ubiquitous. WISH of arterial (grl) and venous (tie1, flt4) markers. A, C, E control embryos; B, D, F 
constitutive expression of NICD. When Notch ICD is over-expressed venous markers are clearly down 
regulated. Arrows and arrowheads highlight the hybridization signals. All the embryos are shown with 
head on the left. (adapted from Lawson et al., 2001). 
 
 
Identification and expression pattern of Numb in mouse 
The gene Numb has been identified in mouse, where encodes four alternatively spliced 
transcripts, which generate four proteins containing the N-terminal PTB domain and a 
C-terminal Proline-Rich Region (PRR, containing putative Src homology 3-binding 
sites; fig. 23). The N-terminus of mNumb shows a similarity with dNumb of 63%, 
while C-terminus shows a lower similarity with the respective region of dNumb (23%; 
Zhong et al., 1996). 
Alternative splicing affects both PTB and PRR domains. A large 48 aa insert in the PRR 
distinguishes Numb1 (653 aa) and Numb3 (642 aa) isoforms (Numb-PRRL) from 
Numb2 (604 aa) and Numb4 (593 aa), which miss it (Numb-PRRS). A smaller 11 aa 
insert in PTB region also distinguishes Numb1 and Numb2 from Numb3 and Numb4 
(fig. 23; Zhong et al., 1996; Dho et al., 1999). This small region of 11 aa seems to 
permit the tethering of the protein to the cell membrane (Dho et al., 1999). 
 
Fig. 23: Structure of Numb isoforms. In mouse, due to alternative splicing, Numb show four isoforms. 
They differ for the presence/absence of an 11 aa insert in the PTB domain and of a 48 aa insert in the 
PRR (adapted from Gulino et al., 2010). 
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Moreover the different isoforms have specific localization. By western blot conducted 
on embryos and on adults tissues it has been observed that Numb3 and 4 are 
ubiquitously diffuse in all adult’s tissues while Numb1 and 2 are detectable only in 
embryos and in adult’s brain, thymus and lung. All these data, taken together, suggested 
a specific role for the different isoforms of the protein (Dho et al., 1999). 
Numb mRNA has been clearly identified both in embryos and in adult. WISH 
demonstrated that mNumb is expressed in all tissues and organ during embryological 
development; especially in Nervous Central and Periferic Systems (NCS and NPS), 
while immuno-histochemistry showed an intense signal of localization of the protein in 
the sites of generation of hemangioblasts and of primitive hematopoiesis (Zhong et al., 
1996; Cheng et al., 2008). 
To complete the expression pattern analysis of mNumb Northern Blot and RT-PCR 
have been conducted on adult tissues; these analyses demonstrated the expression of the 
gene in liver, gut, kidney, brain, lung, spleen, thymus, lymph nodes, bone marrow and 
heart (Zhong et al., 1996; Wilson et al., 2007). 
 
Numb mutant mice: analysis of vascular function 
mNumb function in vascular development has been analyzed by characterization of 
homozygous (Numb-/-) and heterozygous (Numb+/-) mutant mice (Zilian et al., 2001). 
Numb+/- mutants showed the same phenotype of wild type embryos (fig. 24 A,C), while 
Numb-/- mutants died before E11.5 stage cause defect in vascular development (fig. 24 
B,D; Zilian et al., 2001).  
Indeed all the observed homozygous mutants presented defects in the vascular system. 
In those mutants vasculogenesis took place normally but defects in angiogenesis were 
detectable from E10 stage. In detail, capillaries and vessels of cardinal venous plexus 
showed a drastic reduction in number and a clear incorrect shape and failed to connect 
with cranial capillaries; intersomitic vessels seemed to be altered, too (Zilian et al., 
2001). 
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Fig. 24: Requirement of Numb for 
angiogenic remodeling. Normal and mutant 
embryos (left and right panels, respectively) 
from timed pregnancies were analyzed for 
phenotypes at E10.5. Whole-mount anti-
PECAM1 antibody staining of blood vessels 
(A, B) in the head, and (C, D) in the trunk 
region. (A, B) In mutant embryos, vessels 
forming the cardinal vein plexus were reduced 
in number, of irregular diameter, and failed to 
connect with cranial capillaries. (C,D) Anti-PECAM1 antibody staining of intersomitic capillaries at the 
level of the anterior LB. In mutant embryos, intersomitic capillaries were reduced in number, dysmorphic, 
and failed to sprout across the dorsal midline. Instead, occasional endothelial blisters were observed. 
Cardinal vein plexus, asterisk; cranial capillaries and endothelial blister in the trunk, arrow; intersomitic 
capillaries, arrowhead; LB, limb bud. (Zilian et al., 2001). 
  
Moreover at a later stage they also presented pericardial edema and rarely they 
displayed cardiac malformation and developmental delay (Zilian et al., 2001).  
 
Identification and expression pattern of Numblike in mouse 
In mouse Numblike has been cloned and it encodes for a cytoplasmic protein (603 aa) 
that doesn’t show any splicing isoform (fig. 25). mNumblike displays extensive 
aminoacidic sequence homology to mNumb (76%) and to a lesser extent to dNumb 
(63.7%); it contains a PTB domain (N-terminus) as well as a specific poly-glutamine 
repeat (C-terminus) and a typical region made of 41 aa (N-terminus) which are absent in 
mNumb. Inversely mNumblike fails to presents the PRR characteristic of all the 
isoforms of mNumb (fig. 25; Zhong et al., 1997). 
 
 
 
Fig. 25: Structure of Numblike isoform. In mouse, Numblike show only one isoform. It differs from 
mNumb in the typical N-terminal region of 41 aa and in the poly-glutamine repeat, both absent in Numb 
(adapted from Gulino et al., 2010). 
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Numblike expression has been analyzed by immuno-hystochemistry assays and WISH 
(Zhong et al., 1997). At E9.5 stage it is expressed predominantly in the trigeminal 
ganglia while later (E12.5) in all the nervous system. Remarkably mNumblike in the 
neural tube is detectable only in ventricles, where mitosis is modest; nervous tissues 
characterized by intense cell division express principally Numb (Zhong et al., 1997). 
Recently, RT-PCR analyses demonstrated that the mRNA of mNumblike is also 
detectable in hematopoietic organs, as thymus, spleen and lymph nodes (Wilson et al., 
2007). 
 
Numblike mutant mice: analysis of vascular function 
To clarify the function of Numblike in vascular development, mutant mice Numblike-/- 
have been generated. Those mice were viable, fertile and they didn’t show any defect, 
nor embryonically nor in adult organisms (Petersen et al., 2002). It seemed to show that 
Numblike hasn’t any important role during the development of vascular system in mice. 
 
Double mutant mice: analysis of vascular function 
Successively it has been generated double mutant, too (Double Knock Out, DKO). 
Deleting both Numb and Numblike, the resulting mice died prematurely (E9) and at 
early stages they showed more serious defects than in singles mutants. To prevent this 
trouble Petersen and co-worker generated conditional double mutant mice. In a 
Numblike-/- background the gene Numb may be inactivated in a conditional way. Two 
different research groups inactivated Numb at E8.5 and at E9.5 to evaluate the role 
played by these two genes in neurogenesis (Petersen et al., 2002; Li et al., 2003). 
Subsequently DKO mice have been analyzed to understand the function of mNumb and 
mNumblike in development of mesodermal structures. At E8.5 both genes are expressed 
in notochord and in somites and DKO mice presented considerable alteration of these 
structures. Somites seemed to be decreased in size but not in number and were 
comparable to those observed in mutants Numb-/-; notochord was partially or completely 
forked (fig. 26; Petersen et al., 2004; Petersen et al., 2006).  
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Fig. 26: Phenotypes of DKO mice. WISH conducted on embryos at E8.5 using a marker for somites. (A, 
C) control embryo; (B, E) DKO embryo; (D) Numb-/- embryo (adapted from Petersen et al., 2006). 
 
Identification and expression pattern of numb in zebrafish 
In zebrafish it has been identified a hortolog of mNumb, which encodes for a 680 aa 
protein showing the characteristic N-terminal PTB domain and a C-terminal PRR. The 
N-terminus displays a big identity with mice’s (64%) while C-terminus is less 
conserved (fig. 27; Niikura et al., 2006; Reugels et al., 2006).  
 
 
%ID aa zNb zNbl mNb mNbl 
zNb - 68% 59% 48% 
zNbl - - 53% 57% 
 
Fig. 27: Homologs of mouse Numb and Numblike have been identified and cloned in zebrafish. 
Peptide domains of both zNumb and zNumblike compared to murine. Table shows amino acid identity 
percentage. 
 
Alternative splicing affects only PTB domain and generate two proteins of 680 aa and 
669 aa; a 11 aa insert in PTB region distinguish between the isoforms (fig. 28; Reugels 
et al., 2006). This insert is responsible of the tethering of Numb to the cell membrane; 
thereby only the longer isoform may interact with the membrane while the smaller can’t 
(Reugels et al., 2006). 
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Fig. 28: Splicing isoforms of zNumb. In zebrafish alternative splicing affect only PTB domain, 
generating two isoforms; the longer own the 11 aa insert and tether the membrane, while the shorter is 
cytoplasmic (adapted from Reugels et al., 2006). 
 
Both transcripts have been detected by RT-PCR in all embryonic stages analyzed, since 
64 cells stage to 5 dpf (Reugels et al., 2006); moreover RT-PCR assays conducted in 
our laboratory revealed that znumb is also expressed in ovary of adult females and in 
embryonic stages since 1 cell stage to 64 cells stage (fig.29). 
 
 
Fig. 29: Developmental expression of zebrafish isoforms of Numb. Total RNAs retro-transcribed and 
amplified by PCR with isoform-specific primer pairs. Both isoforms are expressed in all stages. A 
fragment of β-actin was amplified as a control (adapted from Reugels et al., 2006). 
 
In order to continue and improve analysis of expression pattern, WISH have been 
conducted in embryos since 1-2 cells stage to 24 hpf. At early stages (1-2 cells - tail 
bud) the transcript was clearly ubiquitously expressed in the entire embryo. During 
somitogenesis the expression signal converged to the midline from the head to the tail 
region (fig. 30) and at later stages (18 somites - 24 hpf) znumb expression became 
restricted to the nervous system and in the eyes (fig. 30). 
 
 
 
 
 
 
 
 33 	  
Fig. 30: numb expression by whole mount in situ hybridization. 
During somitogenesis (13 s and 20 s) a strong signal is found at the 
midline from the head to the tail region. At 24 hpf, its expression is 
restricted in the fore-, mid- and hindbrain and in the eyes. All the 
embryos are shown with head on the left. 
 
 
 
 
 
Identification and expression pattern of numblike in zebrafish 
numblike in zebrafish encode for a protein of 618 aa that exhibits the characteristic PTB 
domain. Otherwise it fails of SRR (peculiar of mNumb and mNumblike), of 41 N-
terminal aa and of poly-glutamine repeats (characteristic of mNumblike; fig. 27, fig. 
31). zNumblike show ≈53% aminoacidic identity with both mNumb and zNumb and 
57% aminoacidic identity with mNumblike. Moreover it is a cytoplasmic protein 
because it doesn’t present the 11 aa insert in PTB domain, necessary for the tethering of 
the protein with the plasma membrane (Niikura et al., 2006; Reugels et al., 2006). 
 
 
 
Fig. 31: Homolog of Numblike in zebrafish. In zebrafish there are no splicing events. The unique 
isoform is cytoplasmic, lacking of the 11 aa insert in the PTB domain (adapted from Reugels et al., 2006) 
 
znumblike expression pattern has been analyzed during embryonic development and in 
different tissues from adult fish by RT-PCR and WISH. 
RT-PCR revealed that mRNA is detectable in all the stages since 1-2 cells to 5 dpf, 
while in adult it is detectable in brain, eye, kidney, muscle, spleen, ovary and skin. It is 
not expressed in heart, liver, testis and gut. 
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Fig. 32: Developmental expression of zebrafish numblike. Total RNAs retro-transcribed and amplified 
by PCR with specific primer pairs. znumblike is expressed in all stages. A fragment of β-actin was 
amplified as a control. 
 
As previously observed in znumb expression pattern analysis, WISH showed that also 
znumblike is ubiquitously expressed during blastula and gastrula stages. Successively 
(13 somites, 15 somites and 20 somites) numblike mRNA was detectable in the central 
nervous system and in the somites (fig. 33). At 24-26 hpf its expression became 
restricted to the nervous system and in the eyes (fig.33).  
 
 
 
Fig. 33: numblike expression by whole mount in situ hybridization. 
During somitogenesis numblike mRNA is  detectable in the central 
nervous system and in the somites. At 24-26 hpf, its expression 
becomes restricted to the nervous system and in the eyes. All the 
embryos are shown with head on the left. 
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MAINTENANCE OF FISH 
Breeding fish were maintained at 28°C on a 14 hours light/ 10 hours dark cycle. They 
are bred in 3-5 liters tanks in three different systems (fig. 34).  
 
Fig.24. One system where fish are maintained. 
 
Embryos obtained from natural spawning were raised and maintained in an incubator at 
28°C in fish water with 0.1% Methylene blue to prevent fungal growth in petri dishes, 
according to established techniques (Kimmel et al., 1995). 
Beginning from 24 hpf, embryos were cultured in fish water containing 0.003% 1-
phenyl-2-thiourea (PTU; Sigma-Aldrich corporation, St. Louis, MO, USA) to prevent 
pigmentation. 
Stock solution for fish water: 34 g of Instant Ocean Sea Salt dissolved in 1 L of 
deionized water. 
Fish water: 50 ml of stock solution in 10 L of deionized water. 
The following lines were used:  
Wild type lines: 
• AB strain: obtained from the Wilson lab, University College London, London, 
United Kingdom. 
Transgenic line: 
• Tg(fli1a:EGFP)y1: Enhanced Green Fluorescent Protein (EGFP) is expressed 
under the control of fli1a gene promoter in a wild type background (from the 
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Lawson lab, University of Massachusetts Medical School, Boston, MA, USA; 
Lawson and Weinstein, 2002a). 
• Tg(kdrl:EGFP)S843: EGFP is under the control of kdrl gene promoter in AB 
background (from the Stainier lab, University of California, San Francisco 
(UCSF), San Francisco, CA, USA; Jin et al., 2005). 
• Tg(gata1:dsRed)sd2;Tg(kdrl:EGFP)S843: dsRed is under control of gata1 gene 
promoter, while EGFP is under control of kdrl gene promoter (from Massimo 
Santoro’s lab, Molecular Biotechnology Center, University of Torino, Turin, 
Italy; Santoro et al., 2007). 
 
MORPHOLINOS INJECTIONS  
Three different antisense morpholinos were synthesized by Gene Tools LLC 
(Philomath, OR, USA):  
ve-ptpMO,   5’ AGGGCTCTGAAACACACACAAACAC 3’  
nbMO   5’ CACACAGCAAAACTTACTTTTTTAA 3’ 
nblMO   5’ CCCACTCTGAGGGTAGAAAAATTGA 3’ 
All of them are splice-blocking MOs designed on an intron/exon boundary. 
Respectively the target of ve-ptpMO is the intron 11/exon 12 boundary; the target of 
nbMO is the exon 4/intron 4; and the target of nblMO is the intron 3/exon 4. As a 
control for unspecific effects, each experiment was performed in parallel with a std-
ctrlMO (standard control oligo), with no target in zebrafish embryos, synthesized by 
Gene Tools LLC:  
std-ctrlMO  5’ CCTCTTACCTCAGTTACAATTTATA 3’ 
All morpholinos were diluted in Danieau Buffer (58 mM NaCl; o,7 mM KCl; 0,4 mM 
MgSO4.H2O; 0,6 mM Ca(NO3)2; 5 mM Hepes pH 7,2; Nasevicius and Ekker, 2000) at 2 
mM and stored at -80°C. 
The injected mixes were made up of: 
• MOs at the desired concentrations, previously heated at 65°C for 5 min. 
• 0.5 ml of rhodamine dextran (Molecular Probes). 
• Danieau Buffer to reach the final volume of 5 ml 
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About 40 embryos was aligned on the edge of a slide that is placed in a Petri dish and 
were injected with 4 nl/embryo of mix at 1–4 cells stage; Rhodamine dextran  was 
usually co-injected as a tracer. 
Microinjection was carried out by using the Micromanipulator 5171 (Eppendorf, 
Hamburg, Germany) and the microinjector FemtoJet (Eppendorf). 
After injection, embryos were raised in fish water at 28ºC and observed up to the stage 
of interest. For a better observation, the injected embryos were anaesthetized using 
0.016% (1X) tricaine (Ethyl 3-aminobenzoate methanesulfonate salt, Sigma-Aldrich 
Corporation; Westerfield, 1995). 
In vivo images were acquired by using a Leica MZ FLIII microscope (equipped with a 
Leica DCF 480 digital camera), provided of the LAS-Leica Application Suite V3 
imaging software (Leica Microsystems GMBH, Wetzlar, Germany). Confocal images 
were acquired with a Leica TCS SP2 AOBS microscope (equipped with an Ar/Kr laser 
and the Leica LAS AF Lite software, Leica Microsystems GMBH). 
After 24 hpf injected embryos were raised with PTU (1-phenil-2-thiourea, Sigma-
Aldrich corporation) 1X at 28 hpf to inhibit the pigmentation and then fixed at the stage 
of interest in 4% PFA/PBS 1X, ON at 4°C.  
• Stock PTU 10X: 0.015 g of powder in 50 ml of fish water. 
• Stock Tricaine 0.4% (25X): 0.08 g of powder in 20 ml of mQ H2O. 
• PBS (Phosphate Buffered Saline) 10X: 180 g NaCl; 2 g KCl; 14,4 g Na2HPO4 • 
2H20; 2,4 g KH2PO4 in 1l of distilled water (pH7.2-7.4). 
Escalating doses of each MO were tested for phenotypic effects. For knockdown 
experiments, it were injected: 0.5 pmol/embryo of ve-ptpMO, 1.3 pmol/embryo of 
nbMO and 0.3 pmol/embryo of nblMO. 
 
DETECTION OF nb AND nblMO EFFICIENCY BY RT-PCR (REVERSE 
TRANSCRIPTION-POLYMERASE CHAIN REACTION) 
Reverse transcription. 
RT-PCR was performed on total RNAs prepared from control embryos and nb and nbl 
morphants at 29 hpf using the RNAgents Total RNA Isolation System (Promega 
Corporation, Madison, WI, USA), treated with DNase I RNase free (Roche, Basel, 
Switzerland) to avoid possible contamination from genomic DNA and then reverse 
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transcribed using the ImProm-II Reverse Transcription System (Promega Corporation) 
and Random primers according to manufacturers' instructions.  
 
PCR (polymerase chain reaction) 
The cDNAs were then subjected to PCR amplification using GOTaq® DNA 
polymerase (Promega Corporation) following the manufacturer’s instructions.  
The following primers were used to determine the efficiency of nbMO:  
SSFOR  5’ CACCAGTGGCAGACCGATGAA 3’ (Ta 61°C); 
SSREV   5’ ACCGCTCGCACAGCCTTCTTA 3’  (Ta 61°C); 
and of nblMO: 
For nbl MOsplice  5’ TCGGGCTGGTGGAGGTGGAT 3’  (Ta 61°C); 
Rev nbl MOsplice  5’ CCGTCACGGCAGATGTAAGAG 3’ (Ta 61°C). 
Primers are synthesized by Invitrogen - Life Technologies (Carlsbad, CA, USA). 
Reaction mixture (25 ml final volume): 
• 5 ml of 5X reaction buffer 
• 0.2 ml dNTPs 25 mM 
• 0.125 ml GoTaq® DNA Polymerase (Promega Corporation) 
• 5 ml cDNA 
• 1.25 ml of both primers 20 mM 
• 12.175 ml sterile H2O 
Cycles for amplification: 
• 1st cycle: 
o 4 min at 95°C (denaturing) 
• 2nd cycle up to 35th 
o 30 sec at 95°C (denaturing) 
o 30 sec at 61°C (annealing) 
o 1 min at 72°C (elongation) 
• last cycle 
o 5 min at 72°C (final incubation) 
Specific b-actin primers (Argenton et al., 2004) were used to check cDNA quality and 
possible genomic contamination. 
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Then the RT-PCR products were run on a 1% agarose gel, photographed on a trans 
illuminator and acquired with Epson 1200 scanner. 
 
WHOLE-MOUNT IN SITU HYBRIDIZATION WISH 
Whole-mount in situ hybridization (WISH) was performed using probes previously 
synthesized in Cotelli’s Lab. The Table showed below display all the probes, the 
restriction enzymes, the vectors and the polymerases used for in vitro synthesis of the 
probes. 
PROBE VECTOR ENZYME RNA pol. 
notch3 - HindIII T3 
dll4 pBSKS+ XhoI T7 
efnb2 pSK SalI T7 
ephB4 pSK XbaI T7 
kdrl pBSSK EcoRI T7 
hey2 pCR2-TOPO NotI Sp6 
flt4 pBS EcoRI T7 
dab2 pBK-CMV SolI T7 
nr2f2 - EcoRI T7 
sox18 pBSKS+ SmaI T7 
cdh5 pCR4-TOPO NotI T3 
myoD - BamHI T7 
Embryos at stage of interest, previously deprived of the chorions, was fixed in 
paraformaldehyde (PFA) 4% in PBS overnight at 4°C; subsequently they have been 
completely dehydrated through 25%, 50% and 75% MeOH/PBS solutions. Fixed 
embryos were stored at -20°C in 100% MeOH (Jowett and Lettice, 1994). 
o Day 1 
• Re-hydrate embryos through: 
- 75% MeOH/25% PBS 1X (5 min at RT) 
- 50% MeOH/50% PBS 1X (5 min at RT) 
- 25% MeOH/75% PBS 1X (5 min at RT) 
• 4 washes with PBT 1X (PBS 1X/Tween 20 1%; 5 min at RT each wash) 
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• Treat embryos in a Proteinase K solution (10 mg/ml in PBT) for: 10 min at RT for 
24 hpf embryos and 12 min at RT for 29 hpf embryos 
• Remove Proteinase K, brief wash in PBT and post-fix for 20 min at RT with PFA 
4%/PBS to block the reaction  
• 5 washes with PBT at RT, 5 min each wash 
• Rinse with HM and incubate at 65°C for 2-5 hours. 
• Denature the probe in HM (300 ng of probe in 400 ml) at 65°C for 5 min 
• Hybridize incubating ON at 65°C with pre-denatured probe  
o Day 2 
• Rinse with fresh HM. 
• Wash for 15 min at 65°C with: 
- 75% HMw /25% SSC 2X 
- 50% HMw /50% SSC 2X 
- 25% HMw /75% SSC 2X 
- SSC 2X 
• Wash twice for 30 min in SSC 0.1X at 65°C 
• Wash for 10 min at RT with: 
- 75% SSC 0.1X /25% PBT 
- 50% SSC 0.1X /50% PBT 
- 25% SSC 0.1X /75% PBT 
- PBT 
• Block in dark for at least 2 hours at RT in PBT/ 2% sheep serum/ 2 mg/ml BSA, 
gently shaking. 
• Incubate in dark ON at 4°C in fresh PBT/ 2% sheep serum/ 2 mg/ml BSA 
containing 1:5000 antidig antibody conjugated with alkaline phosphatase (Roche), 
previously pre-absorbed for at least 2 hours at RT in PBT/ 2% sheep serum/ 2 
mg/ml BSA containing zebrafish embryos homogenate. 
o Day 3 
• Rinse with PBT at RT 
• Wash 6 times for 15 min with PBT at RT  
• Wash 3 times for 5 min with Stainig Buffer 
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• Incubate at RT in dark in Staining Solution, until the staining develops. To avoid the 
background due to endogenous alkaline phosphatases, Staining Buffer contain also 
0.24mg/ml levamisole (Tetralevamisole, Sigma-Aldrich corporation). 
• To stop the reaction rinse twice with PBT. 
• Post-fix in PFA 4%/PBS for 30 min at RT 
o Solutions 
• 10X PBS: 180 g NaCl; 2 g KCl; 14,4 g Na2HPO4 • 2H20; ; 2,4 g KH2PO4 in 1l of 
distilled water (pH7.2-7.4). 
• PBT: PBS 1X + 1% Tween 20. 
• 20X SSC: 3 M NaCl; 0.3 M C6H5Na3O7 • 2H2O (sodium citrate) pH 7.0. 
• HM (Hybridization mix): 50% formamide (Fluka, Sigma-Aldrich corporation); 5X 
SSC; 1M C6H8O7 (citric acid) pH 6; 500 µg/ml Yeast RNA; 0.1% Tween 20; 50 
µg/ml heparin. 
• HMw (Hybridization mix wash): 50% formamide ; 5X SSC; 1M C6H8O7 (citric 
acid) pH 6; 0.1% Tween 20. 
• Staining Buffer: 100 mM NaCl; 100 mM Tris HCl pH 9.5; 50 mM MgCl2; 0,1% 
Tween 20. 
• Staining Solution: staining solution + BM Purple (diluted 1:2) 
 
Images of stained embryos were taken with a Leica MZFLIII epifluorescence 
stereomicroscope equipped with a DFC 480 digital camera and Leica Application Suite 
LAS V3 imaging software. 
 
MICROANGIOGRAPHY 
Dechorionated tg(fli1:EGFP)y1 embryos at 2 dpf were anesthetized with tricaine (Sigma-
Aldrich corporation) and located on a gel bed made of agarose; then Dextran-TMR 
(tetramethylrhodamine; molecular weight 70 kDa, Molecular Probes) have been 
injected. Dextran-TMR was dissolved in PBS at 25 mg/ml and microinjected into the 
sinus venosus or just ventro-posterior to the Sinus Venosus (Weinstein et al., 1995).  
Specimens were scanned using a Leica TCS SP2 AOBS microscope confocal 
microscope. For each sample, two images of the fluorescent tracer dye were collected, 
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10 min (t1) and 15 min (t2) after the dye injection. Pictures of the fluorescent vascular 
tree were also taken. The collected data were processed by ImageJ 1.41o: the pictures 
obtained at t1 were subtracted to the images obtained at t2 to evaluate changes of 
fluorescence occurred in 5 min for each injected embryo.  
 
HISTOLOGICAL SECTIONS AND ELECTRON MICROSCOPY 
Histological sections 
Microinjected embryos were fixed, embedded in epoxy resin and sectioned. 
o Fixation: 
• Fix the samples at 4°C ON with a modified form of Karnovsky Fixative 
(Karnovsky, 1965), made up of 2.5% glutaraldehyde, 2% of paraformaldehyde and 
cacodilate buffer (sodium cacodilate in distilled water and chloridric acid) 0.1 M pH 
7.4 
• Rinse three times with cacodilate buffer 0.2 M pH 7.4 (5 min at RT) 
• Wash in cacodilate buffer 0.2 M pH 7.4 at 4°C ON 
• Post-fix in osmium tetroxide 2% in cacodilate buffer 0.1 M pH 7.4 (about 2-2.5 
hours) 
• Wash in cacodilate buffer 0.2 M pH 7.4 
o Embedding: 
• De-hydrate embryos through 35%-100% EtOH solutions  
• Wash quickly in propylene oxide (5 min) 
• Incubate for at least 3 hours at RT in a mix made up of 50% propylene oxide and 
50% of epoxy resin (Epon 812- Araldite)  
• Incubate in 100% epoxy resin (Epon 812- Araldite) at RT ON 
• Embed embryos for 48hours at 68°C in 100% epoxy resin (Epon 812- Araldite) 
 
Embedded samples were sectioned with a Reichter UltracutE ultra-microtome using 
glass blades. Semi-thin sections, 0.5-0.7 mm, were collected on SuperFrost slides (Bio 
Optica SpA, Milano, Italy), dried and rinsed with sodium metoxide, MeOH and EtOH, 
to remove the resin. Successively they were stained with gentian violet and basic 
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fuchsin and mounted with Eukitt (Bio Optica SpA). All slides were observed with a 
Leica DM6000 B microscope, equipped with a digital camera Leica DCF480 and 
provided of LAS-Leica Application Suite V3 imaging software (Leica Microsystems 
GMBH). 
 
Electron microscopy 
Microinjected embryos were fixed, embedded in epoxy resin and sectioned. 
o Fixation: 
• Fix the samples at 4°C ON with a modified form of Karnovsky Fixative 
(Karnovsky, 1965), made up of 2.5% glutaraldehyde, 2% of paraformaldehyde and 
cacodilate buffer (sodium cacodilate in distilled water and chloridric acid) 0.1 M pH 
7.4 
• Rinse three times with cacodilate buffer 0.2 M pH 7.4 (5 min at RT) 
• Wash in cacodilate buffer 0.2 M pH 7.4 at 4°C ON 
• Post-fix in osmium tetroxide 2% in cacodilate buffer 0.1 M pH 7.4 (about 2-2.5 
hours) 
• Wash in cacodilate buffer 0.2 M pH 7.4 
o Embedding: 
• De-hydrate embryos through 35%-50% EtOH solutions  
• Incubate in dark at least 3 hours in 2% uranyl acetate solution (in 50% EtOH) gently 
shacked  
• De-hydrate embryos through 50%-100% EtOH solutions  
• Wash quickly in propylene oxide (5 min) 
• Incubate for at least 3 hours at RT in a mix made up of 50% propylene oxide and 
50% of epoxy resin (Epon 812- Araldite)  
• Incubate in 100% epoxy resin (Epon 812- Araldite) at RT ON 
• Embed embryos for 48hours at 68°C in 100% epoxy resin (Epon 812- Araldite) 
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Embedded samples were sectioned with a Reichter UltracutE ultra-microtome using 
diamond blades. Thin sections, about 80 nm, were collected on copper grid (thin mesh), 
stained with lead citrate (Reynolds, 1963) and coated with a thin carbon film using the 
carbon vacuum evaporator Emitech K400X. All the sections were observed and 
photographed using a transmission electron microscopy Jeol 100SX TEM. Plates were 
processed, and then acquired with an Epson Perfection 3710 scanner. 
 
Statistical analysis 
Statistical analysis was performed with Student’s t-test or one-way ANOVA followed 
by Dunnett’s post-test, when needed, using GraphPad PRISM version 5.0 (GraphPad, 
San Diego, CA, USA). A p value of <0.05 indicates a statistically significant effect. 
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Results 
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Functional characterizations of zve-ptp, znumb and znumblike were conducted via loss-
of-function assays, by microinjecting specifics morpholinos: ve-ptpMO, nbMO and 
nblMO. In this work it has been microinjected for each morpholino previously tested 
doses. The dosage setting was performed on wild type embryos belonging to AB strain 
and the experimental doses were fixed to 0.5 pmol/embryo for ve-ptpMO, 1.3 
pmol/embryo for nbMO and 0.3 pmol/embryo for nblMO. 
 
ve-ptp LOSS-OF-FUNCTION EXPERIMENTS  
ve-ptpMO is a splice-blocking morpholino designed on the intron 11/exon 12 boundary 
that cause the skipping of the 12th exon during splicing events. This exon encode for the 
FNIII domain closest to the cell membrane, so probably in morphants it is translated an 
altered isoform of zVe-ptp, lacking just this domain.  
In order to demonstrate this alteration of splicing events were conducted RT-PCR 
experiments. Those assays performed on morphant’s RNA showed the presence of two 
specific transcripts while control embryos displayed only one transcript for zve-ptp 
mRNA. These data confirmed the presence of a non-physiological mRNA in embryo 
micro-injected with ve-ptpMO. 
 
Transmission electron microscopy 
As described before, consequently to the microinjection of ve-ptpMO embryos 
exhibited vascular defects ascribable to alteration of permeability caused to irregular 
conformation of endothelial junctional complexes. For instance morphants showed 
cephalic micro-haemorrhages and clots of erythrocytes in vessels. 
With the aim to investigate the endothelial junction’s structure and highlight eventual 
alterations it was conducted an ultra-structural analysis of endothelium of main axial 
vessels, through Transmission Electron Microscopy (TEM; fig.25). 
Examining transverse sections collected from several areas, in trunk and tail region of 
different embryos microinjected with std-MO, it was detected a lot of junctions between 
endothelial cells (fig.25A, A’). Conversely, identify endothelial junctional complexes 
that surround DA and PCV/CV in morphants was quite difficult. The boundaries 
between cells usually lacked of junctions and only occasionally they showed few 
complexes of disorganized electrondense material (fig.25B, B’).  
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Fig.25. Ultra-structural analysis of endothelial junctions in control embryos (A, C) and morphants 
injected with ve-ptpMO (B, D). Transversal sections of embryos collected in trunk region (A, B); 
transversal sections of embryos collected in caudal region (C, D). (A’, B’, D’, D”) Higher magnification 
of the boxed areas. It is possible to observe the abundance of junctions (black arrowheads) between 
endothelial cells of control embryos (A, A’) and their complete absence in morphants’ endothelium (B, 
B’). In morphants’ tail it was noted filopodia (asterisks; D, D’, D”). er, eritrocytes; EC, endothelial cell; 
L, lumen of vessels. Black arrowheads, junctions; asterisks, filopodia. Bar: 2 µm in A, B, C and D; 1 µm 
in A’, B’,D’ and D”. 
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It was very interesting to note that in embryos microinjected with ve-ptpMO, 
endothelial cells of CV also exhibited alterations of the cell membrane. In fact these 
cells displayed digitiform membrane protrusions of the membrane, which were 
ascribable to filopodia (microspikes) and were completely absent in control sections 
(fig.25C-D”). 
These structures, quite crucial for a correct interaction between two cells membrane, 
may be related to an immature phase of junctions’ development, in which cells contact 
their neighbours but they are not yet able to generate permanent junctions structures.  
Statistical analysis of ultra-structural defects 
To validate the data collected by TEM and to attribute them a quantitative meaning, it 
was conducted a thorough statistical analysis.  
Because of the complexity of data collection via TEM, it was considered as “n” the 
single boundary between two different endothelial cells observed through electron 
microscopy, with the aim of obtaining a significative statistic. Moreover, several 
regions of different embryos (3 controls and 7 morphants) were examined to provide 
higher variability in this investigation.  
So 112 boundaries were analysed from control embryos and 150 boundaries from 
morphants. Subsequently it was determined if the observed boundaries showed or not 
junctional complexes. 
In controls 98 EC-EC boundaries exhibited at least one junctional complex (88.5%) and 
only 14 didn’t displayed any complex (11.5%; fig.26). Contrariwise in morphants only 
43 region showed adhesive complexes (29%), while 107 boundaries were lacking of 
junctions (71%). It is very interesting to note that in 29 examined region (20%) of 
embryos microinjected with ve-ptpMO, it were clearly identified the digitiform 
structures just described (filopodia; fig.26A, C). Overall morphants displayed a five-
fold decrease in the ratio of number of endothelial junctional complexes with respect to 
controls, while the rate of junctions per boundary diminished from 1.24 to 0.48 from 
control to morphants. 
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Fig.26. Quantitative analysis of % EC-EC borders. (A) Cumulative graph of the rate of EC-EC 
boundaries with any type of junctions (adherens and/or tight junctions), without junctions and without 
junctions but with filopodia in controls and in zve-ptp morphants. Singles graphs of the data belonging to 
each class: with junctions (B), without junctions but with filopodia (C) and without junctions (D). The 
analysis was performed on the acquired images of trunk and tail regions. Three std-MO and seven zve-ptp 
MOb injected embryos were analyzed. *** p<0.001 vs std-MO. 
 
Microangiography assays.   
With the purpose of supporting the working hypothesis, namely that the loss of function 
of Ve-ptp resulted in a change in vascular permeability, it have been conducted micro-
angiography assays. Cause to the absence of considerable haemorrhages our goal was to 
demonstrate a change in permeability that would allows only the leakage of haematic 
fluid and not of blood cells. 
So a fluorescent dye was injected in the cardiovascular system of control embryos and 
of morphants at the stage of 2 dpf. Micro-angiographed embryos were observed using a 
confocal microscope in two moments: 10 minutes after the microinjection of dye (t1) 
and 15 minutes after the microinjection of dye (t2). Successively each image obtained at 
t2 was compared to the corresponding image obtained at t1 to evaluate the dye leaked 
from the vessels in 5 min (fig.27). 
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Moreover, to further highlight an eventual extravasation of dye, endothelial transgenic 
line Tg(fli1a:EGFP)y1, that express the green fluorescent protein EGFP in endothelial 
cells, was used to conduct this analysis and the images of dye and of vessels were added 
via imaging software (fig.27E-F).   
The vast majority (62%) of micro-angiography experiments conducted on control 
embryos didn’t show extravasation of dye (fig.27A, C, E) while morphants clearly 
exhibited a drastic increase of fluorescence outside from the vessels, indicative of dye 
extravasation (fig.27B, D, F). Must affected regions were the CV plexus and the 
DLAVs (fig.27F’, F”).  
The statistical analysis indicate that only 38% (n=29) of control embryos showed dye 
extravasation, indicative of physiologic outflow, contrariwise 80% of morphants 
displayed this defect (n=32).  
 
numb AND numblike LOSS-OF-FUNCTION EXPERIMENTS  
In order to perform the functional characterization of the genes numb and numblike, two 
different morpholinos was microinjected separately: nbMO and nblMO. nbMO was 
designed on the exon 4/intron 4 boundary and cause the skipping of the 4th exon during 
splicing events, without changing the sequence reading frame. This exon encodes for 
the characteristic sequence 11 aa long, responsible for the tethering of the protein to the 
cell membrane. The resulting altered protein might be a cytosolic form of Numb and the  
modified mRNA might coincide to one of the two physiological splicing isoform of the 
transcript. To demonstrate this hypothesis it was conducted an RT-PCR assay with 
specific primers, on cDNA retrotranscribed from total RNA extracted from 29 hpf 
embryos microinjected with std-ctrlMO and nbMO (fig.28). In control embryos it was 
clearly detected two bands while in morphants only a lower length band (fig.28A). 
Successively this band was sequenced and it coincided (more than 99% identity) to the 
sequence of the transcript of cytosolic isoform of Numb. Basically, microinjection of 
nbMO altered the physiological balance between the two isoforms of Numb, towards 
cytoplasmic one.  
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Fig.27. Micro-angiography assays performed on control embryos (A, C, E) and morphants 
microinjected with ve-ptpMO (B, D, F). Confocal microscopy images of the tail collected at t1 (10 min 
post-injection of the die; A and B) and at t2 (15 min post-injection of the die; C and D). (E and F) merger 
of vessels’ picture and of  circulating fluorescent die’s picture; (A’-E”) higher magnification of the boxed 
areas. Asterisks highlight the leakage of die from the vessels in the morphants. 
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nblMO, designed on the intron 3/exon 4 boundary, was a splice-blocking morpholino, 
too. Its interaction with the numblike transcript caused the skipping of the 4th exon 
during splicing events, without altering the sequence reading frame. This exon encodes 
for a portion of the PTB domain. To clarify if nblMO microinjection really may change 
splicing events generating a non-physiologic mRNA it was conducted a RT-PCR 
experiments with specific primers, on cDNA retrotranscribed from total RNA extracted 
from 29 hpf control embryos and from morphants (fig.28). Effectively RT-PCR 
performed on RNA extracted from embryos microinjected with nblMO showed two 
different transcripts, one corresponding to the physiological mRNA and one shorter, 
probably corresponding to the non-physiologic nbl mRNA generated as a result of the 
micro-injection of the specific morpholino (fig.28B).  
 
Fig.28. Qualitative RT-PCR analysis to test nbMO (A) and nblMO (B) efficiency. The first and the 
second lanes of each panel show respectively amplified cDNA from uninjected embryos (uninj) and from 
embryos microinjected with std-ctrlMO. The third lanes of each panel show the amplified cDNA from 
morphants; numb morphants in A and numblike morphants in B. The central lane is the marker.  In 
control embryos were seen two different bands for numb mRNA, and only one for numblike mRNA. 
Contrariwise numb morphants show only one band (178 bp), referred to the cytosolic isoform of Numb, 
while numblike morphants show two different bands (246 bp and 171 bp), referred to a physiologic and 
an altered form (shorter) of Numblike. 
 
Phenotype of knocked down embryos  
Microinjected embryos were observed in vivo at 2 dpf (fig.29). Embryos microinjected 
with nbMO and embryos microinjected with nblMO showed evident defects if 
compared with control embryos. Sure enough morphants exhibited mild cerebral 
oedemas and yolk extensions thinner than controls. As a rule, morphants’ body plans 
resulted unaffected (fig.29A, B, C). 
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Employing the transgenic line Tg(gata1:dsRed)sd2;Tg(kdr:EGFP)S843, that express the 
red fluorescent protein dsRed in blood cells and the green fluorescent protein EGFP in 
endothelial cells, it was possible to observe in vivo vascular and circulatory defects. At 
the analysed stage both vasculogenesis and first intersegmental angiogenic event are 
already occurred. So in the trunk/tail region of a 2 dpf embryo is possible to distinguish  
two main axial vessels (DA and PCV/CV plexus) and a well organized series of ISVs. 
Embryos microinjected with nbMO and embryos microinjected with nblMO showed a 
drastic reduction in dorsoventral size of CV plexus, if compared with control embryos 
(fig.29). This defect was detected analysing vessels structure (in green; fig.29D, E, F) 
and confirmed studying circulation (in red; fig.29 G, H, I). Blood flow examination has 
also allowed the characterization in vivo of a significant approach between the two main 
axial vessels in the trunk (fig.29 G, H, I). Honestly, despite neither circulation nor 
heartbeat were affected, blood flow observation has been very difficult, because 
morphants showed a reduction in number of erythrocytes. It is due to the fact that numb 
and numblike are involved in blood cells differentiation, as proved by previous studies 
(Bresciani et al., 2010). 
Furthermore morphants displayed alterations of ISVs that lost their characteristic 
arrowhead shape and didn’t seem to be still patent; nevertheless in this work the 
attention was focalized to the defects of main axial vessels.  
All the decribed defects were detectable in both morphants but with different rate and 
severity. Sure enough embryos microinjected with nbMO displayed milder defects and 
a lower ratio of phenotypes (28%, n=495). Contrariwise embryos microinjected with  
nblMO showed defects more pronounced than numb morphants and a higher ratio of 
phenotypes (64%, n=637). 
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Histological analysis 
To better characterize the defects of main axial vessels examined in vivo it was 
performed a histological investigation conducting semi-thin transverse sections of 
morphants’ trunk and tail (fig.30). 
Comparing sections obtained from the trunk of embryos microinjected with nbMO and 
nblMO with sections obtained from the trunk of controls (fig.30, line I) it was observed 
that as a rule in morphants DA and PCV were not altered in shape or size, they were 
always luminized and they didn’t display any evident defects of endothelium (fig.30A); 
in addition blood cells was detectable inside both main axial vessels. Transverse 
sections confirmed the approach of DA and PCV and permitted to evaluate the 
alteration of the distance between these two vessels (fig.30B, C). This distance was 
measured directly on the collected images of the sections, and then it was calculated the 
average distance for each embryo (1 control embryo, 2 numb morphants, 2 numblike 
morphants; almost 50 measuring per embryo). Comparing the data collected analyzing 
the transverse sections it was observed that numb morphants exhibited approximately 
50% decrease of vessels distance, while numblike morphants showed about 80% 
decrease. Moreover vein lumina were larger in morphants than in controls (fig.30G). 
In the tail of a 2 dpf embryo vascular tree is characterized by a single artery, the DA, 
and a vein organized in a complex plexus of vessels, the CV. In this plexus it is possible 
to identify a “preferential way” followed by red blood cells, corresponding to the most 
ventral vessel. Examining transverse section, these preferential vessels of the plexus are 
larger than the others and show the widest lumen (fig.30D). Morphants showed, as a 
rule, CVs with lumen wider than controls, and the DA and the most ventral vessel of 
CV closer than in embryos microinjected with std-ctrlMO (fig.30, line II). As for trunk 
sections, even in tail it was measured the distance between DA and the main vessel of 
CV, it was calculated the average and it was noted that numb morphants displayed 
approximately 30% decrease of width of the space between vessels, while numblike 
morphants exhibited about 90% decrease of the distance measured (1 control embryo, 2 
numb morphants, 2 numblike morphants; almost 50 measuring per embryo; fig.30H). 
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Fig.30. Morphological analysis of numb and numblike morphants. Transverse semi-thin plastic 
sections of 2 dpf embryos microinjected with std-ctrlMO (A, D), nbMO (B, E) and nblMO (C, F); at the 
level of trunk (A, B and C) and tail (D, E and F) region. In the insets, higher magnifications of the space 
between the main axial vessels (boxed areas). Morphants sections show a drastic approach of the arterial 
and venous vessels (highlighted by inset and/or arrows), both in the trunk and in the tail; moreover 
numblike morphants exhibit a self-evident enlargement of the vein calibre. Erhitrocytes are detectable in 
the lumen of the vessels. Statistical analysis of vein-artery approach made measuring average of main 
axial vessels distance in trunk (G) and tail (H) region. The top image shows the section planes: I, trunk; 
II, tail. *** p<0.001 vs std-MO. DA, Dorsal Aorta; PCV, Posterior Cardinal Vein; vCV, most Ventral 
vessel of Caudal Vein; arrow, DA-PCV/DA-vCV distance. 
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Molecular analysis  
The molecular analysis was conducted by WISH assays on 29 hpf embryos 
microinjected with std-ctrlMO, nbMO and nblMO. The embryonic stage was selected 
considering that starting from 28/29 hpf the vessels begin to express different specific 
markers, in accordance with their arterial-venous identity. 
 
• Expression of Notch pathway markers 
With the aim of highlighting potential alterations in the expression of the major 
molecules involved in this signalling cascade it has been characterized the expression 
pattern of notch3 and dll4. 
 
o notch3 
The gene notch3 encodes for the vascular specific isoform of Notch. At 29 hpf this 
transcript is detectable, via WISH, in CNS and in DA (Lawson et al., 2001). Embryos 
microinjected with nbMO (n=60) and with nblMO (n=58) exhibited a marked increase 
of hybridization signal (respectively 72% and 53% of embryos) if compared with 
control embryos (n=70; 92% of embryos with unaffected phenotype; fig.31A, C, E). 
 
o dll4 
The gene dll4 encode for one of the Notch ligands expressed in vascular endothelium, 
Dll4 (Delta like ligand 4). Although it is not the preferential ligand of Notch3, previous 
data displayed that this receptor may interact with Dll4 protein, too (Hsiao et al., 2007; 
Indraccolo et al., 2009; Serafin et al., 2011). At 29 hpf dll4 was expressed in ISVs and 
in DA (Leslie et al., 2007). Comparing hybridization signal in morphants (nbMO n=14; 
nblMO n=13) and in control embryos (n=12), no evident alteration were detectable 
(fig.31B, D, F). 
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• Expression of Eph-ephrin signalling pathway markers  
As described thorough before, previous studies proved that Notch pathway plays a key 
role in arterial-venous differentiation of endothelial cells during embryonic 
development. In particular Notch may influence the consecutive expression of specific 
arterial or venous markers pertaining to Eph-ephrin signalling pathway (Wang et al., 
1998; Lawson et al., 2001; Domenga et al., 2004). 
The Ephrin ligand Efnb2 and Ephrin receptor EphB4 were identified in the late 1980's 
and they were linked to different physiological and pathophysiological processes like 
embryonic development, angiogenesis and tumorigenesis.  
In order to characterize any alteration in expression pattern of these markers it has been 
conducted WISH assays with specific probes.  
 
o efnb2 
The gene efnb2 encodes for a trans-membrane ligand, Efnb2 (Ephrin B2), and in 29 hpf 
embryos it is expressed in specific region of CNS and in DA (Adams et al., 1999).  
Fig.31. Expression of Notch pathway markers: notch3 (A, C, E) and dll4 (B, D, F). WISH on 
embryos at 29 hpf microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). In the insets, 
higher magnification of the boxed areas. notch3 hybridization signal increase in morphants if compared 
with control embryos. White arrow, hybridization signal in DA. All the embryos are shown with the head 
on the left. 
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Comparing data obtained from WISH conducted on controls (n=39) and on embryos 
microinjected with nbMO (n=64; fig32A) and with nblMO (n=41), hybridization signal 
in the main arterial vessel of morphants resulted increased (29% and 72% of embryos), 
both in the trunk and in the tail (fig.32C, E). Nevertheless no ectopic expression has 
been detected. The probe is kindly provided by R. Patient. 
 
o ephB4 
The gene ephB4 encodes for EphB4 (Ephrin B4 receptor) a trans-membrane tyrosine 
kinase receptor having a high affinity binding to Efnb2 (Adams et al., 1999). At 29 hpf 
it is specifically expressed in specialized region of CNS, in lateral line primordium, in 
PCV and in CV plexus. 
Embryos microinjected with nbMO (n=82) and with nblMO (n=74) and hybridized with 
the specific probe, kindly provided by R. Patient, showed a drastic reduction of the 
signal in main venous vessels (31% and 65% of embryos; fig.32D, F), particularly 
evident in CV plexus, if compared with embryos microinjected with std-ctrlMO (n=55; 
fig.32B).  
 
Fig.32. Expression of arteriovenous markers: efnb2 (A, C, E) and ephB4 (B, D, F). WISH on 
embryos at 29 hpf microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). In the insets, 
higher magnification of the boxed areas. To note the increase of efnb2 hybridization signal and the 
dicrease of ephB4 in morphants. All the embryos are shown with the head on the left. 
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• Expression of arterial-venous identity markers 
Alteration of efnb2 and EphB4 expression may have been related to a modification in 
arterial-venous identity acquisition of main axial vessels endothelium. In order to 
confirm that hypothesis were conducted WISH assays, to investigate expression 
patterns of arterial-venous identity markers involved in the Notch pathway.  
 
o kdrl 
The gene kdrl encodes for the protein Kdrl (Kinase insert domain receptor like), a 
tyrosine kinase receptor for Vegf (Holmes and Zachary, 2007). At 29 hpf the transcript 
is exclusively expressed in arterial vessels (Fouquet et al., 1997). 
In numb and numblike morphants (n=14 and n=15 respectively; fig.33C, E) 
hybridization signal resulted considerably increased, if compared with embryos 
microinjected with std-ctrlMO (n=16; fig.33A). 
  
o hey2 
The gene hey2 encodes for the protein Hey2 (Hairy/enhancer-of-split related with 
YRPW motif protein 2), a transcription factor that interact with a histone deacetylase 
complex. Notch signaling pathway induces the expression of this gene, although a very 
recent work demonstrate that hey2 in zebrafish lays upstream of notch during 
haematopoiesis (Leimeister et al., 1999; Rowlinson and Gering, 2010). In embryos at 
29 hpf the transcript is detectable in some specific area of CNS and in DA along its 
entire length, both in trunk and tail (Zhong et al., 2001). 
Morphants microinjected with nbMO (n=50) and with nblMO (n=45) showed a strong 
increment of the hybridization signal (respectively 31% and 57% of embryos; fig.33D, 
F), if compared with control embryos (n=61; 98% of embryos with unaffected 
phenotype; fig.33B). No ectopic signal was detected. 
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Fig.33. Expression of arterial-venous identity markers (I): kdrl (A, C, E) and hey2 (B, D, F). WISH 
on embryos at 29 hpf microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). In the 
insets, higher magnification of the boxed areas. An increase of hybridization signals in the arterial vessels 
was detected in morphants. All the embryos are shown with the head on the left. DA, Dorsal Aorta; PCV, 
posterior Cardinal Vein. 
 
o flt4 
The gene flt4 encodes for the protein Flt4 (Fms-related tyrosine kinase 4), a tyrosine 
kinase receptor for VegfC and VegfD, involved in lymphangiogenesis and maintenance 
of the lymphatic endothelium (Petrova et al., 1999). At 29 hpf this gene is specifically 
expressed in venous vessels of head, trunk and tail (Thompson et al., 1998).  
Comparing the hybridization signal observed in embryos microinjected with std-ctrlMO 
(n=31; fig.34A) with numb and numblike morphants (n=22 and n=43, respectively) it 
resulted that both microinjected embryos showed a drastic reduction in the expression 
of this venous marker (35% and 72% respectively; fig.34C, E). 
 
o dab2 
The gene dab2 is exclusively expressed in venous endothelium and encodes for the 
protein Disabled homolog 2 (Dab2; Hocevar et al., 2003). At 29 hpf in control embryos 
it is expressed in venous vessels of head, trunk and tail (Song et al.,2004).  
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In numb and numblike morphants (n=66 and n=65 respectively) hybridization 
signals resulted unaltered (fig.34D, F), if compared with embryos microinjected 
with std-ctrlMO (n=110; fig.34B). 
In the order 10% and 21% of samples exhibit a mild increase in the intensity of 
hybridization signal. 
 
 
Fig.34. Expression of arterial-venous identity markers (II): flt4 (A, C, E) and dab2 (B, D, F). WISH 
on embryos at 29 hpf microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). In the 
insets, higher magnification of the boxed areas. A mild reduction of flt4 hybridization signal in the 
venous vessels was detected in morphants (C, E). All the embryos are shown with the head on the left. 
DA, Dorsal Aorta; PCV, posterior Cardinal Vein. 
 
o nr2f2 
nr2f2 encodes for the transcriptional factor Nr2f2 (nuclear receptor subfamily 2, group 
F, member 2) also known as COUP-TFII, which plays a critical role in controlling the 
development of a number of tissues and organs including heart, venous blood vessels, 
muscles and limbs (Pereira et al., 1999; Lee et al., 2004). In embryos at 29 hpf the 
transcript is detectable in some specific area of CNS, eyes, PCV and CV plexus (probe 
kindly provided by R. Wilkinson). 
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Morphants microinjected with nbMO (n=35) and with nblMO (n=21) didn’t show any 
alterations of the hybridization signal if compared with control embryos (n=41; fig.35A, 
C, E). 
 
o sox18 
The gene sox18 encodes for the transcriptional factor Sox18 (SRY-related HMG-box 
18) involved in the regulation of embryonic development and in the determination of 
the cell fate. In detail this protein plays a role in blood vessel and lymphatic vessels 
development (Garcìa-Ramirez et al., 2005; François et al., 2008). At 29 hpf the 
transcript is expressed in all vascular system (Cermenati et al.,2008).  
In numb and numblike morphants (n=67 and n=56 respectively) hybridization signal 
resulted considerably reduced (33% and 78% of embryos; fig.35D, F) in both arterial 
and venous vessels, if compared with embryos microinjected with std-ctrlMO (n=49; 
92% of embryos with unaffected phenotypes; fig.35B). 
 
Fig.35. Expression of arterial-venous identity markers (III): nr2f2 (A, C, E) and sox18 (B, D, F). 
WISH on embryos at 29 hpf microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). In 
the insets, higher magnification of the boxed areas. A strong reduction of sox18 hybridization signal was 
detected in morphants (D, F). All the embryos are shown with the head on the left. DA, Dorsal Aorta; 
PCV, posterior Cardinal Vein. 
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As observed in previous experiments, alteration in embryos microinjected with nblMO 
was, as a rule, stronger than in numb morphants both in percentage of embryos 
displaying the variation and in intensity of signal modification. 
  
• Expression of vascular and myogenic markers   
To demonstrate that the observed alterations of arterial-venous identity markers in nb 
and nbl morphants were not due to a drastic modification of the cardiovascular system 
or to a developmental delay it has been evaluated the expression of a vascular pan-
endothelial marker and of a myogenic marker. 
 
o cdh5 
The vascular marker cdh5 encodes for the protein Cdh5 also known as VE-cadherin, a 
junctional protein exclusively expressed in endothelial cells (Dejana, 2004). At 29 hpf 
cdh5 is detectable via WISH in all embryonic vessels, both arterial that venous (Larson 
et al., 2004). Comparing morphants and control embryos it was not observed drastic a 
lteration of the expression pattern of ve-cadherin (fig.36A, C, E). 
 
o myoD 
The gene myoD encodes for MyoD, a transcription factor belonging to the protein 
family of myogenic regulatory factors (MRFs), which display a key role in regulating 
muscle differentiation. Moreover MyoD is one of the earliest markers of myogenic 
commitment (Emerson, 1993; Weintraub, 1993; Olson and Klein, 1998). myoD is 
expressed in all somites highlighting the number and consequently the developmental 
stage of embryo (Weinberg et al., 1996). WISH to detect myoD expression was 
conducted on embryos at 24hpf. Morphants microinjected with nbMO and with nblMO 
was not affected by developmental delay, displaying the same number of somites if 
compared to controls (fig.36B, D, F). Moreover they didn’t show any alteration of 
somites shape, further evidence that morphants body plan was correctly developed 
(fig.36B, D, F). 
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Fig.36. Expression of a vascular marker, cdh5 (A, C, E), and a myogenic marker, myoD (B, D, F). 
WISH on embryos at 29 hpf, for the vascular marker, and 24 hpf, for the myogenic marker. The analysed 
embryos were microinjected with std-ctrlMO (A, B), nbMO (C, D) and nblMO (E, F). Both the examined 
markers were basically unaltered, comparing control embryos and morphants. All the embryos are shown 
with the head on the left. 
 
 
Double knockdown assays 
To test the hypothesis that numb and numblike may play redundant roles in vascular 
development double knockdown assays have been conducted, simultaneously 
microinjecting both nbMO and nblMO at low doses.  
Low doses of morpholinos (0.65 rmol/embryo of nbMO and 0.15 rmol/embryo of 
nblMO) injected separately (fig.37) caused morphologic alterations of the 
cardiovascular system at a lower rate if compared with embryos microinjected with 
higher doses (fig.37). In particular microinjection of low doses of nbMO caused the 
21% of phenotypes (n=151) and microinjection of low doses of nblMO caused the 26% 
of phenotypes (n=141). When low doses were coinjected in the same embryos, 63% 
(n=91) of the double morphants exhibited the characteristic approach of the two main 
axial vessels of the trunk and the typical reduction in dorsoventral size of CV plexus 
(fig.37). 
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During Vertebrate embryogenesis one of the first apparatus to be formed is the cardio-
vascular system. The cell lineages, which give rise to this system, originate from 
common mesodermal progenitors that subsequently differentiate in endothelial cells 
(Risau and Flamme, 1995; Vogeli et al., 2006), haematopoietic cells (Song et al., 2004), 
cardiomyocytes and endocardial cells (Lee et al., 1994). 
Blood vessels network develops through two consecutive processes, vasculogenesis and 
angiogenesis (Risau, 1997; Roman and Weinstein, 2000). In the course of 
vasculogenesis angioblasts, the endothelial cells predecessors, aggregates to form de 
novo the primitive vascular plexus (Risau and Flamme, 1995). Afterwards, through 
sprouting, migration of endothelial cells and remodelling of pre-existing vessels, 
angiogenesis leads to the formation of a complex network of arteries and veins with 
different calibre. These processes are finely regulated by many angiogenic pathways 
and often linked to dissociation and formation of endothelial junctions (Risau, 1997; 
Roman and Weinstein, 2000). 
The formation of a correct cardio-circulatory system has a crucial role during embryo 
development, cause to the essential functions of this apparatus. Sure enough blood 
vessels carry oxygen to tissues and take away catabolites and waste products. Moreover, 
vessels network serve as a way for transport of hormones, allowing communication 
between distant regions of the body. 
In this work we focalized our attention on two processes, which play a crucial role 
during vascular development, the correct assembly of endothelial junctions and the 
acquisition of the arterial-venous identity of endothelial cells. 
* * * 
Cell-cell adhesion is critical for the development and maintenance of multicellular 
organisms. In the blood vessels the intactness of cell-cell adhesion is essential for a 
functional vascular system. The endothelial cells are one of the main cellular 
constituents of blood vessels, and one of their most important functions is to separate 
blood from underlying tissues (Stevens et al., 2000). Endothelial cells have complex 
junctional structures that are formed by transmembrane adhesive proteins that bind, 
with their cytoplasmic domain, to intracellular partners anchoring them to cytoskeletal 
filaments (Dejana, 2004). The correct link between these proteins and the cytoskeleton 
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is important for the junction stability and for the dynamic regulation of junction opening 
and closure (Schnittler, 1998; Dejana, 2004). A crucial concept is that cell–cell 
junctions are not only sites of attachment between endothelial cells, but they can also 
function as signalling structures that communicate cell position, limit growth and 
apoptosis, and regulate vascular homeostasis (Dejana, 2004). Therefore, any change in 
junctional organisation might have complex consequences, which could compromise 
the interaction between endothelium and blood elements or modify the normal 
architecture of the vessels wall (Dejana, 2004). The stability of many adhesion junctions 
is related with tyrosine phosphorylation level of the adhesion molecules and their 
associated components; usually high levels of phosphorylation promote the junction 
disassembly (Daniel and Reynolds, 1997). At adherens junction the adhesion between 
vascular endothelial cells is mediated by the transmembrane protein VE-cadherin, 
which through its extracellular domain physically interacts with Ve-ptp (Nawroth et al., 
2002). Murine Ve-ptp is the first known receptor-type tyrosine phosphatase that is 
preferential expressed in endothelial cells (Fachinger et al., 1999; Bäumer et al., 2006). 
The analysis of mutant and null-mice phenotypes suggested that the deletion of mVe-ptp 
causes severe cardiovascular defects and embryonic lethality from E10 stage for 
angiogenic and remodelling defects (Bäumer et al., 2006; Dominguez et al., 2007). In a 
previous work performed in our laboratory it was identified an homolog of mVe-ptp 
also in zebrafish. Through loss-of-function experiments it has been investigate the role 
of zVe-ptp, microinjecting a specific morpholino, ve-ptpMO; the microinjected embryos 
displayed in vivo cephalic haemorrhages and clots in the CV plexus and subsequent 
analysis of semi-thin plastic sections confirmed the described phenotypes. This 
characterisation strongly suggested an involvement of zVe-ptp in the maintenance of the 
cardiovascular system intactness and functionality. It has been supposed that leaks in 
the vessels wall could be related to a loss of adhesion at the level of the endothelial 
junctions, caused by an alteration of protein tyrosine phosphorylation level of adhesive 
molecules. Previous work had demonstrated that association between Ve-ptp and VE-
cadherin regulate the phosphorylation level of the last one and that it is accompanied by 
the enhancement of the adhesive function of vascular cadherin itself (Nawroth et al., 
2002). These data strongly suggest that Ve-ptp might influence VE-cadherin activity 
and, therefore, might play a crucial role in endothelial adherens junction stability. In 
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order to validate this hypothesis thorough ultrastructural analyses and micro-
angiography assays were carried out. 
With the aim of investigating the ultrastructure of blood vessels in trunk/tail region of 
morphants, we analyzed thin (about 80 nm thick) plastic sections of these anatomical 
districts by means of transmission electron microscopy (TEM). This analysis revealed a 
drastic reduction in number of adhesive structure and a generalized disorganization of 
endothelial AJs. Indeed only 29% of samples showed electron-dense structures located 
on the boundaries between ECs. Nevertheless, these structure was never organized as 
properly formed AJs, strongly suggesting that formation of these junctions has been 
severely affected, although not always prevented (71% of samples). This datum seems 
to indicate that the expression of adhesive proteins was not damaged, although might be 
an incorrect interaction between them.  
The most striking feature of ECs in ve-ptp morphants at 2 dpf, in contrast to controls 
ECs at the same stage, is the presence of digitiform protrusions, referred to as filopodia, 
detected in 28% of affected EC-EC boundaries. These plasma-membrane extensions are 
transitional structures essential to initiate a cell-cell contact. When the cadherins of the 
neighbor cells establish stable bonds, the protrusions retire, AJs mature and the cell 
contact appears as a closed zipper (Vasioukhin et al., 2000; Brevier et al., 2008; 
Miyoshi and Takai, 2008). We speculate that endothelial AJs in morphants presented an 
immature structure in which VE-cadherins could be unable to contact each other in 
order to form the correct and mature adhesion complex, because of an altered 
phosphorylation level of junction members.  
As previously described, vascular phenotypes caused by microinjection of ve-ptpMO 
seem to be related to loss of continuity between EC, which may alter permeability of 
endothelium. 
In order to further investigate these defects in morphants we performed micro-
angiography assays. In zebrafish this technique is usually used to visualise the entire 
vascular tree in vivo injecting fluorescent beads or fluorescent dye into the blood flow 
(Weinstein et al., 1995). In a recent work an alexafluor 555-labeled BSA was injected 
into the zebrafish blood flow at 2 dpf with the purpose to evaluate vessels permeability 
(Liu et al., 2007). By microangiography experiments, conducted on ve-ptpMO 
microinjected embryos, it was detected an increased extravasation of the dye out of the 
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CV plexus and of the DLAVs with respect to controls (80% vs 38% extravasation, 
respectively), confirming in vivo an increased vascular permeability due to the 
functional knockdown of ve-ptp. It is interesting to note that dye extravasation 
phenomena were noticed in body region characterized by angiogenesis and high rate of 
vascular remodelling, as previously remarked also for in vivo phenotypes. This 
observation completely fit with earlier data showing that this protein play a crucial role 
in angiogenesis (Bäumer et al., 2006; Dominguez et al., 2007).  
In conclusion the obtained results confirm that zVe-ptp is involved in the zebrafish 
cardiovascular development. In particular it seems to play a key role in the modulation 
of vascular permeability and/or functionality and in the maturation and stability of 
endothelial AJs. 
* * * 
Arteries and veins are structurally different: the morphologic characteristics of their 
walls and the expression of specific receptors/ligands by their endothelium are the 
distinctive features that highlight the diversity between these vessels. For a long time 
experimental data demonstrate that arterial-venous identity acquisition was related to 
the direction of blood flow (Clark, 1918; Girard, 1973; Gonzales-Crussi, 1971). 
However, recent studies indicates that the identity of the endothelial cells that line 
arteries and veins is determined in the developing embryo, before circulation begins 
(Wang et al., 1998). The use of zebrafish as model system led to the identification of 
several signalling pathways that are responsible for arterial and venous differentiation of 
endothelial cells and demonstrated definitively that endothelial cell-fate decision is a 
critical step for normal blood vessels formation (Lawson and Weinstein, 2002).  
Two early signalling pathways act determining arterial or venous specification of 
endothelial cells, SHH and Notch pathways (Smithers et al., 2000; Lawson et al., 2001; 
Villa et al., 2001). Shh is expressed in the notochord and induces the expression of vegf 
in the mesodermal tissues lying laterally (Lawson et al., 2002). The consequent 
activation of VEGF/VEGFR2 pathway determines the expression of notch in 
angioblasts positioned dorsally and the resulting expression of arterial-identity markers. 
Contrariwise the non-activation of Notch pathway in angioblasts located more ventrally 
allows the expression of venous-identity markers (Odenthal et al., 1996; Lawson et al., 
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2002; Lawson and Weinstein, 2002).  
Previous studies conducted on D. melanogaster and on mice showed that Notch 
signalling pathway may be regulated by Numb and Numblike, which interact directly 
with the protein Notch, recruiting Itch and leading to polyubiquitination and 
degradation of the NICD (McGill and McGlade, 2003; McGill et al., 2009). 
Furthermore Numb may also control the intracellular trafficking of Notch, causing 
endocytosis and sequestration of full-length Notch or of the NICD. Therefore 
expression of Numb and Numblike produces the suppression of Notch function and may 
be involved in Notch pathway regulation also in vascular network formation (Knoblich, 
2008; Gulino et al., 2010).  
Numb and Numblike function in vascular development has been first analyzed in mice 
by characterization of mutant mice. Numb-/- mutant mice died before E11.5 stage 
because of defects in angiogenesis remodelling events of cranial capillaries and of 
intersomitic vessels (Zilian et al., 2001). Inversely Numblike-/- mutant mice didn’t show 
any defect, nor embryonically nor in adult organisms (Petersen et al., 2002). All these 
data taken together suggest that mNumb play a crucial role in vascular development, 
especially during angiogenesis, while mNumblike hasn’t any important function during 
the development of vascular system in mice.  
In order to investigate the role of znumb and of znumblike during vascular development 
loss-of-function experiments have been performed, microinjecting two specific 
morpholinos, nbMO (1.3 pmol/embryo) and nblMO (0.3 pmol/embryo), designed to 
block the maturation of transcripts and therefore the translation of Numb and Numblike 
in zebrafish. Interestingly both the knockdown of numb and of numbl resulted in an 
evident alteration of cardiovascular system, consisting in the approach of the main axial 
vessels in trunk and a reduction in size of CV plexus in tail. In particular numb 
morphants observed in vivo at 2 dpf showed the 28% of phenotypes while numblike 
morphants, at the same developmental stage, exhibited a higher ratio of phenotypes, 
64% of affected embryos. Consecutive morphological investigation of plastic sections 
conducted on trunk and tail region confirmed the defects detected in vivo; moreover a 
statistical analysis of distance DA/PCV and DA/most ventral vessel of CV highlighted 
that the approach due to microinjection of nblMO was stronger than that due to 
microinjection of nbMO; respectively 80% VS 50% of reduction degree in the trunk and 
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90% VS 30% in the tail. Intriguingly all these data seemed to suggest not only that both 
Numb and Numblike might be involved in zebrafish vascular development, contrary to 
what happens in mice (Petersen et al., 2002), but also that Numblike could play a role 
more important than that played by Numb.  
Due to the interaction described from Numb/Numblike and Notch and their ability to 
antagonize it functions, the knockdown of the genes encoding for these two proteins 
could turns up the activation level of Notch and of its pathway. It’s important to note 
that this may be possible only in those anatomical districts where notch is already 
expressed. Sure enough knockdown of znumb and znumblike didn’t cause ectopic 
expression of notch; it exclusively stimulated Notch activation where it’s 
physiologically expressed. Notch signalling pathway is crucial for vascular 
development and for the determination of arterial and venous identity of endothelial 
cells (Xue et al., 1999; Krebs et al., 2000; Thurston and Yancopoulos, 2001; Raya et al., 
2003; Krebs et al., 2004). A common consequence of the incorrect identity acquisition 
of endothelial cells, related to an alteration of this pathway, is the non-physiological 
fusion of arteries and veins, called shunts (Lawson et al., 2001; Duarte et al., 2004; 
Krebs et al., 2004; You et al., 2005). So, we speculate that the observed phenotypes 
may be a milder version of shunts described in previous studies; we also hypothesize 
that in our morphants vessels move toward without completely fusing together, because 
of the alteration of Notch pathway. 
With the aim of corroborating the idea that detected phenotypes were related to a wrong 
acquisition of arterial-venous identity, was carried out a thorough analysis of the 
expression pattern of specific vascular markers. Markers of Notch signalling pathway, 
notch3 and dll4 were considered first. These markers are specifically expressed in the 
developing vascular system, and encodes respectively for a Notch receptor isoform and 
a Notch ligand. In morphants the expression of notch3 was increased, while the 
expression of dll4 was unaltered. Previous works assessed and confirmed the presence 
of a positive feedback loop regulating notch expression (Cagan and Ready, 1989; 
Artavanis-Tsakonas et al. 1999, Del Monte et al., 2007). This regulating process might 
be responsible of the described increase of notch expression level, almost certainly 
caused to an over-activation of the protein Notch.  
In a very short time we plan to validate these data using embryos of a Notch-inducible 
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transgenic line and performing rescue assays both microinjecting specific orthologue 
mRNA and treating morphants with specific substances which inactivate Notch 
pathway (DAPT; Geling et al., 2002). 
Successively it has been considered markers of arterial-venous identity. As previously 
described, some studies indicates that angioblasts may be directed towards an arterial or 
venous destiny before blood vessels formation and before the onset of circulation 
(Lawson and Weinstein, 2002). Moreover previous studies about notch deletion and 
constitutive expression, performed in zebrafish mib mutants and in embryos in which 
NICD expression is ubiquitous, showed that notch expression decrease is followed by 
reduction of arterial specific markers (as efnb2) and increased of venous specific 
markers (as flt4); conversely intensification of notch expression results in diminution of 
venous markers (as flt4) and improve of arterial markers (as grdl; Lawson et al., 2001). 
In our experiments numb and numblike morphants showed an evident increasing in 
arterial markers expression (efnb2, kdrl and hey2) and a drastic reduction of venous 
markers expression (ephB4 and flt4), strongly suggesting that the observed vascular 
defects were linked to over-activation of Notch. Interestingly other markers which lay 
upstream of notch (as nr2f2) or which are not involved in Notch pathway (as dab2) 
were unaltered in morphants, proving that alteration of arterial-venous identity was 
exclusively related to specific modification of Notch signalling pathway in developing 
vascular system. 
In future we purpose to carry out real-time quantitative RT-PCR, with the aim to 
confirm and quantify the increase/decrease of the analysed vascular markers.  
The subsequent analysis of a pan-endothelial vascular marker, cdh5, and a myogenic 
marker, myoD, excluded that the observed defects of vascular markers expression might 
be caused by severe alteration of body plan, to defects of vascular network structure or 
to a significant developmental delay. Sure enough both the vascular tree morphology 
and the number and the shape of somites of morphants were comparable with those of 
controls.  
Mammalian Numb and Numblike proteins are believed to have overlapping functions, 
although distinct localization in the cell and specific expression pattern (Gulino et al., 
2010). In fact Numblike is symmetrically distributed while, in contrast, Numb is 
asymmetrically localized to the apical membrane of dividing cells (Zhong et al., 1996). 
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Nevertheless in vivo studies revealed a redundant function for Numb and Numbl in mice 
(Petersen et al., 2002). Very recent studies confirmed it also in zebrafish (Bresciani et 
al., 2010). Numb and Numblike act as regulator proteins in many different 
developmental processes but their redundancy is not detectable in all of them. For 
example numb and numblike seem to play redundant role in haematopoiesis, both in 
mice (in vitro approach) and in zebrafish, and in neurogenesis (Petersen et al., 2002; 
Cheng et al., 2008; Bresciani et al., 2010). Conversely during mice vascular 
development Numb and Numblike play different roles, in particular mNumb plays a 
critical role in angiogenesis, while mNumblike appear dispensable (Zilian et al., 2001; 
Petersen et al., 2002).    
The data showed in this work, strongly suggest that, conversely to what happen in mice, 
both znumb and znumblike play a critical function during arterial-venous differentiation 
of endothelial cells, although with different degrees. It raise a query about a potential 
interaction between zNumb and zNumblike. In order to assess this possibility, double 
knockdown assays were carried out, first injecting separately low doses (0.65 
pmol/embryo of nbMO and 0.15 pmol/embryo of nblMO) of the morpholinos and then 
co-injecting simultaneously both morpholinos together. As a result microinjecting 
separately the low doses of morpholinos, the ratio of phenotypes were lower than those 
obtained microinjecting separately the high doses of morpholinos (21% VS 28% for 
numb morphants and 26% VS 64% for numblike morphants). Intriguingly co-injecting 
both morpholinos together the ratio of phenotypes improve, reaching 63% of embryos 
exhibiting the described phenotypes. These data strongly assert that znumb and 
znumblike play a redundant, and probably synergic, role in vascular development. 
In Vertebrates lymphatic system arise from pre-existing vessels. In zebrafish venous 
endothelial cells migrate from PCV to form venous InterSomitic Vessels (vISV) and 
Lymphatic Precursors Cells (LPCs). Subsequently LPCs first move along arterial 
InterSomitic Vessels (aISV) and then along myoseptum, towards the space between DA 
and PCV, where give rise to the Thoracic Duct (TD; Yaniv et al., 2006). Cause to the 
reduction of the space where the TD will develop and to the decrease of expression of 
venous markers, we speculated about a possible alteration of lymphangiogenesis due to 
knockdown of znumb and znumblike. In order to confirm this hypothesis it was assessed 
sox18 expression. Recent works gave to this transcription factor a crucial role in 
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lymphatic development in mice, identifying it as an upstream regulator of prox1, which 
play a crucial for lymphatic development (Francois et al., 2008). Our experiments 
pointed out a drastic decrease of sox18 expression level, suggesting a role for numb and 
numblike in lymphangiogenesis, and laying the foundation for a new and gripping 
research topic. 
In conclusion these data prove that znumb and znumblike act in concert controlling the 
acquisition of arterial-venous identity and influencing the signalling pathway mediated 
by Notch. 
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EMBRYONIC DEVELOPMENT OF ZEBRAFISH 
The zebrafish eggs are small (400-500 µm), with a very large yolk mass. After the 
fertilization, several cytoplasmic rearrangements occur, and these events lead to the 
segregation of the cytoplasm to the animal pole, and the yolk mass to the vegetal pole. 
The segmentation (cleavage) is meroblastic and relative to the cytoplasm of the animal 
pole only. In this way, the formation of the “blastula” is observed. The blastula starts 
the gastrulation period, which is characterized by different cellular movements. Kimmel 
et al., (1995), distinguished the following developmental stages: zygote period (0-3/4 
hpf), cleavage period (3/4-21/4 hpf), blastula period (21/4-51/4 hpf), gastrula period (51/4-10 
hpf), segmentation period (10-24 hpf), pharingula period (24-48 hpf) and hatching 
period (48-72 hpf). 
 
 
Zygote Period  
The newly fertilized egg is in the zygote period until the first cleavage occurs, about 40 
minutes after fertilization. The chorion swells and lifts away from the newly fertilized 
egg. Fertilization also activates cytoplasmic movements, easily evident within about 10 
minutes. Nonyolky cytoplasm begins to stream toward the animal pole, segregating the 
blastodisc from the clearer yolk granule-rich vegetal cytoplasm. This segregation 
continues during early cleavage stages.  
 
Cleavage Period  
After the first cleavage the blastomeres divide at about 15-minute intervals. The 
cytoplasmic divisions are meroblastic; they only incompletely undercut the blastodisc, 
and the blastomeres, or a specific subset of them according to the stage, remain 
interconnected by cytoplasmic bridges. The six cleavages that comprise this period 
frequently occur at regular orientations and are synchronous. The cleavage period ends 
at 64-cell stage (2 hpf).  
 
 
Blastula Period 
We use the term blastula to refer to the period when the blastodisc begins to look ball-
like, at the 128-cell stage, or eight zygotic cell cycle, and until the time of onset of 
gastrulation, about cycle 14. Important processes occur during this blastula period; the 
embryo enters midblastula transition (MBT), the yolk syncytial layer (YSL) forms, and 
epiboly begins. Epiboly continues during the gastrulation period. Three different phases 
can be observed.  
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-Early-blastula: the marginal blastomeres lie against the yolk cell and remain 
cytoplasmatically connected to it throughout cleavage. Beginning during cycle 10, the 
marginal cells undergo a collapse, releasing their cytoplasm and nuclei together into the 
immediately adjoining cytoplasm of the yolk cell and forming the Yolk Syncytial Layer 
(YSL). After the YSL forms, the enveloping layer cells (EVL) that were in the second 
blastodisc tier, now lie at the marginal position and they are nonsyncytial.  
-Mid-blastula: the YSL nuclei continue to undergo mitotic divisions in the midblastula, 
but the nuclear divisions are unaccompanied by cytoplasmic ones, and the yolk remains 
uncleaved and syncytial. After about three cycles, and coinciding with the beginning of 
epiboly, the YSL divisions abruptly cease. The YSL nuclei now begin to enlarge, 
possibly meaning that they are actively transcribing RNA. The YSL, an organ unique to 
teleosts, may be extraembryonic, making no direct contribution to the body of the 
embryo. At first the YSL has the form of a narrow ring around the blastodisc edge, but 
soon it spreads underneath the blastodisc, forming a complete “internal” syncytium (I-
YSL), that persists throughout embryogenesis. In this position, the I-YSL might be 
presumed to be playing a nutritive role. Another portion of it, the E-YSL, is transiently 
“external” to the blastodisc edge, and appears to be a major motor for epiboly.  
-Late-blastula: epiboly beginning in the late blastula is the thinning and spreading of 
both the YSL and the blastodisc over the yolk cell. During the early stages of this 
morphogenetic movement the blastodisc thins considerably, changing from a high-piled 
cell mound to a cup-shaped cell multiplayer of nearly uniform thickness. This is 
accomplished by the streaming outward, toward the surface, of the deepest blastomeres. 
As they move, they mix fairly indiscriminately among more superficial cells along their 
way, except for the EVL and the marginal blastomeres. These nonmixing marginal 
blastomeres will give rise to the mesoderm, and suggest the existence of a pattern 
established during early development. At 30% epiboly stage, the proper blastoderm 
begins to develop: it is uniform and formed by the EVL monolayer and a deep cells 
multilayer (Deep Enveloping Layer, DEL).  
 
 
Gastrula Period 
The beginning of involution defines the onset of gastrulation, and, so far as we have 
been able to tell, this occurs at 50%-epiboly. As a consequence, within minutes of 
reaching 50%-epiboly a thickened marginal region termed the "germ ring" appears, 
nearly simultaneously all around the blastoderm rim. Convergence movements then, 
nearly as rapidly, produce a local accumulation of cells at one position along the germ 
ring, the so-called embryonic shield. During these events, epiboly temporarily arrests, 
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but after the shield forms, epiboly continues; the margin of the blastoderm advances 
around the yolk cell to cover it completely. The advance occurs at a nearly constant rate, 
over an additional 15% of the yolk cell each hour, and providing a useful staging index 
during most of gastrulation. Just as there was no blastocoele during the blastula period, 
there is no archenteron in the gastrula. Neither is there a blastopore; DEL cells involute 
at the blastoderm margin, which thus plays the role of the blastopore. Involution 
produces the germ ring by folding the blastoderm back upon itself. Hence, within the 
germ ring there are two germ layers: the upper, the epiblast, continues to feed cells into 
the lower, the hypoblast, throughout gastrulation. Between the two layers a fissure, 
termed "Brachet's cleft" is observed. Cells in the two layers are streaming in different 
directions. Except for the dorsal region, the epiblast cells generally stream toward the 
margin, and those reaching the margin move inward to enter the hypoblast. Then, as 
hypoblast cells, they stream away from the margin. The cells remaining in the epiblast 
when gastrulation ends correspond to the definitive ectoderm and will give rise to such 
tissues as epidermis, the central nervous system, neural crest, and sensory placodes. The 
hypoblast gives rise to derivatives classically ascribed to both the mesoderm and 
endoderm. At tail-bud stage (10 hpf), cell specifications processes are ending while cell 
differentiation mechanisms are turned on.  
 
Segmentation Period 
A wonderful variety of morphogenetic movements now occur, the somites develop, the 
rudiments of the primary organs become visible, the tail bud becomes more prominent 
and the embryo elongates. The AP and DV axes are unambiguous. The first cells 
differentiate morphologically, and the first body movements appear. Somites develop 
sequentially in the trunk and tail, and provide the most useful staging index. Anterior 
somites develop first and posterior ones last. Pronephric kidneys appear bilaterally deep 
to the third somite pair. The notochord differentiates, also in an AP sequence. Some of 
its cells vacuolate and swell to become the structural elements of this organ, and others 
later form a notochord sheath, an epithelial monolayer that surrounds the organ. 
Endoderm develops on only the dorsal side of the embryo, beneath the axial and 
paraxial mesoderm. The epiblast, now exclusively ectodermal, undergoes extensive 
morphogenesis during the segmentation period. As gastrulation ends, the primordium of 
the central nervous system, the neural plate, is already fairly well delineated, because of 
its prominent thickness. The anterior region where the brain will form is particularly 
thick. Formation of the neural tube then occurs by a process known as "secondary 
neurulation". Secondary neurulation contrasts with "primary" neurulation, the version in 
vertebrates where a hollow tube forms from the neural plate by an uplifting and meeting 
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together of neural folds. In teleosts the lumen of the neural tube, the neurocoele, forms 
by a late process of cavitation.  
 
 
 
 
 
 
 
An intermediate and transient condensed primordium with no lumen, the neural keel, 
forms first. Because the times of neurulation and segmentation overlap so extensively 
the zebrafish does not have a distinct "neurula period" of development, such as occurs 
largely before segmentation in amphibian embryos.  
 
Pharyngula Period 
The pharyngula period (24-48 hpf) begins with the formation of the last somites (30/34 
somites). At this time, the notochord is completely formed, and the brain is constituted 
by three lobes, which develop in an AP direction: forebrain, midbrain and hindbrain.  
 
 
 
 
 
 
 
 
Hatching Period 
During the last period, termed "hatching" (48-72 hpf), individuals within a single 
developing clutch hatch sporadically during the whole third day of development (at 
standard temperature), and occasionally later. At this time, we call these embryos 
"larvae"; morphogenesis of many organ rudiments is completing, and the embryo 
continues to grow at about the same rate.  
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